Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NC_000017.10:g.(?_29422308)_(29701193_?)dup	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001060911	17	29422308 - 29701193			1060911	1039215		
NC_000017.10:g.(?_29622128)_(29701173_?)dup	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV001041201	17	29622128 - 29701173			1041201	1022378		
NC_000017.11:g.(?_31095030)_(31374155_?)dup	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000833390	17	29422048 - 29701173			833390	820999		
NC_000017.11:g.(?_31248964)_(31352434_?)dup	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 21, 2019)	criteria provided, single submitter	VCV000833381	17	29575982 - 29679452			833381	821023		
NC_000017.11:g.(?_31248974)_(31352424_?)dup	EVI2A|EVI2B|NF1|OMG		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000832415	17	29575992 - 29679442			832415	821025		
NC_000017.10:g.(?_29422318)_(29701183_?)dup	EVI2A|EVI2B|NF1|OMG|LOC108281169|LOC108281170|LOC108281180|LOC108281181|LOC108281182|LOC111811965		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000583654	17	29422318 - 29701183	17	31095300 - 31374165	583654	570757		
F9, ALU INSERTION, EX5	F9		Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Apr 1, 1993)	no assertion criteria provided	VCV000010654					10654	25693		
NM_000267.3(NF1):c.289-1171_888+1963dup	LOC108281180|LOC108281181|NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217106	17	29489033 - 29511646	17	31162015 - 31184628	217106	213682		
NC_000017.10:g.(?_29422322)_(29701179_?)dup	LOC111811965|OMG|LOC108281169|LOC108281170|LOC108281180|LOC108281181|LOC108281182|EVI2A|EVI2B|NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000527682	17	29422322 - 29701179	17	31095304 - 31374161	527682	530475		
NM_001042492.3(NF1):c.4_5delinsTT (p.Ala2Phe)	LOC111811965|NF1	A2F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480205	17	29422331 - 29422332	17	31095313 - 31095314	480205	477975	rs1555594471	NC_000017.11:31095312:GC:TT
NM_001042492.3(NF1):c.-237dup	LOC111811965|NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000322557	17	29422087 - 29422088	17	31095069 - 31095070	322557	337800	rs886052788	NC_000017.11:31095069:CCCC:CCCCC
NM_001042492.3(NF1):c.-242dup	LOC111811965|NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000322556	17	29422082 - 29422083	17	31095064 - 31095065	322556	344021	rs886052787	NC_000017.11:31095064:CCCC:CCCCC
NM_001042492.3(NF1):c.-249_-247dup	LOC111811965|NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000322555	17	29422076 - 29422077	17	31095058 - 31095059	322555	344012	rs886052786	NC_000017.11:31095058:CCCCC:CCCCCCCC
NM_001042492.3(NF1):c.-248_-247dup	LOC111811965|NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000322554	17	29422076 - 29422077	17	31095058 - 31095059	322554	344013	rs886052786	NC_000017.11:31095058:CCCCC:CCCCCCC
NM_001042492.3(NF1):c.6352dup (p.Leu2118fs)	NF1	L2097fs, L2118fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319469	17	29663854 - 29663855	17	31336836 - 31336837	1319469	1309722		NC_000017.11:31336836:CCC:CCCC
NC_000017.10:g.(29687722_29701030)_(29704696_?)dup	NF1		not specified	Uncertain significance(Last reviewed: Jul 29, 2021)	criteria provided, single submitter	VCV001192231	17	29687722 - 29704696			1192231	1182202		
NM_001042492.3(NF1):c.1527+14dup	NF1		Neurofibromatosis, type 1	Benign(Last reviewed: Nov 18, 2020)	criteria provided, single submitter	VCV001167481	17	29541610 - 29541611	17	31214592 - 31214593	1167481	1157929		NC_000017.11:31214592:TTTTTTT:TTTTTTTT
NM_001042492.3(NF1):c.5911_5914dup (p.Thr1972fs)	NF1	T1951fs, T1972fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV001076932	17	29661952 - 29661953	17	31334934 - 31334935	1076932	1064065		NC_000017.11:31334934:AGTTA:AGTTAGTTA
NM_001042492.3(NF1):c.5721_5722insTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTNNNNNNNNNNNNNNNCAGGATAGTCTCGATCTCCTGACCTCGTGATCCGCCCGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCGCGCCCGGCCAACAACACCCTCTTT (p.Ile1908delinsPhePhePhePhePhePhePhePhePhePheXaaXaaXaaXaaXaaXaaGlyTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV001076369	17	29657407 - 29657408	17	31330389 - 31330390	1076369	1064060		
NM_001042492.3(NF1):c.7666dup (p.Arg2556fs)	NF1	R2535fs, R2556fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV001076106	17	29683524 - 29683525	17	31356506 - 31356507	1076106	1064120		NC_000017.11:31356506:AAAA:AAAAA
NM_001042492.3(NF1):c.7439_7440insG (p.His2480fs)	NF1	H2459fs, H2480fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 14, 2020)	criteria provided, single submitter	VCV001076096	17	29677318 - 29677319	17	31350300 - 31350301	1076096	1064112		NC_000017.11:31350300::G
NM_001042492.3(NF1):c.8142dup (p.Ala2715fs)	NF1	A2694fs, A2715fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001075957	17	29686012 - 29686013	17	31358994 - 31358995	1075957	1064134		NC_000017.11:31358994:TTT:TTTT
NM_001042492.3(NF1):c.2487dup (p.Asp830Ter)	NF1	D830*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001075813	17	29556119 - 29556120	17	31229101 - 31229102	1075813	1063960		NC_000017.11:31229101:T:TT
NM_001042492.3(NF1):c.1477_1525dup (p.Cys509fs)	NF1	C509fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001075205	17	29541550 - 29541551	17	31214532 - 31214533	1075205	1063923		NC_000017.11:31214532:TTCTCTTGTCCATGGTGAAACTAATTCATGCAGATCCAAAGCTCTTGCTTT:TTCTCTTGTCCATGGTGAAACTAATTCATGCAGATCCAAAGCTCTTGCTTTCTCTTGTCCATGGTGAAACTAATTCATGCAGATCCAAAGCTCTTGCTTT
NM_001042492.3(NF1):c.3822_3823insG (p.Phe1275fs)	NF1	F1275fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001075136	17	29562742 - 29562743	17	31235724 - 31235725	1075136	1064004		NC_000017.11:31235724::G
NM_001042492.3(NF1):c.4933_4934insGGCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGTGGATCATGAGGTCAGGAGATCGAGACCATCCTGGCTAACAAGGTGNNNNNNNNNNAAAAAAAAAAAAAAAAAAAAGAAATTGTAGTGGACC (p.Leu1645delinsArgProGlyAlaValAlaHisAlaCysAsnProSerThrLeuGlyGlyArgGlyGlyTrpIleMetArgSerGlyAspArgAspHisProGlyTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV001075043	17	29652919 - 29652920	17	31325901 - 31325902	1075043	1064037		
NM_001042492.3(NF1):c.8172_8179dup (p.Tyr2727fs)	NF1	Y2706fs, Y2727fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV001075040	17	29687514 - 29687515	17	31360496 - 31360497	1075040	1064135		NC_000017.11:31360496:TTCCAGACT:TTCCAGACTTCCAGACT
NM_001042492.3(NF1):c.2993dup (p.Tyr998Ter)	NF1	Y998*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001074965	17	29557279 - 29557280	17	31230261 - 31230262	1074965	1063974		NC_000017.11:31230261:A:AA
NM_001042492.3(NF1):c.129_130insGGGAATACATTATTATGTAAACTTAATTTTAAAAGACAGGAGAAAATCTGTTTTCTGCTGACCAAAGAAGTGACTTATTGATACAAAAGGAACACTAAAGTACAAAAATACCCACTGTCAATAATATGATACAGAGTTAGCAAACCATATACATGATCTCCATGTGGTTATGAATGTAATAGTTGTAAGTGGGTGAGTATTAATACACATTATTTTACGGTTGCAAGTTCACTAGGATCAATTAATCTAATGCAATGGTCAACAATATGACTTCATATGTTAATTGCCTGGGTTTACTATGGGATGATACTGCCAGAAAAGGCTTATGAGACAAGAAAATTACTTCGTGGGATAGCATTTGGTAACTTCCACTGAGAAGTAGAAATTATCTGATTTGTTAGCAAAGAAGGCTAGTGACAACGTACCTCCTGTCGGGCTGGTGCTGCATGTGGCCAGTCTCCTCTGGACAATCCTGTAACATGGGCTGGAGTTCTTCCTGTGGGGAGGGAGTCAGAGTGGCAGTGGACTGATGGCTATAGGACACGGCAGCTGGAGAAGAAGCTGTCTA (p.Ile44delinsGlyAsnThrLeuLeuCysLysLeuAsnPheLysArgGlnGluLysIleCysPheLeuLeuThrLysGluValThrTyrTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV001074815	17	29483063 - 29483064	17	31156045 - 31156046	1074815	1063884		
NM_001042492.3(NF1):c.2899dup (p.Ile967fs)	NF1	I967fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001074763	17	29556900 - 29556901	17	31229882 - 31229883	1074763	1063968		NC_000017.11:31229882:A:AA
NM_001042492.3(NF1):c.5736_5737delinsAT (p.Ser1912_Lys1913delinsArgTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 25, 2020)	criteria provided, single submitter	VCV001074730	17	29657440 - 29657441	17	31330422 - 31330423	1074730	1064061		NC_000017.11:31330421:TA:AT
NM_001042492.3(NF1):c.2318dup (p.Asn773fs)	NF1	N773fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001074513	17	29554299 - 29554300	17	31227281 - 31227282	1074513	1063951		NC_000017.11:31227281:AAA:AAAA
NM_001042492.3(NF1):c.4190dup (p.Gln1399fs)	NF1	Q1378fs, Q1399fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001074069	17	29585375 - 29585376	17	31258357 - 31258358	1074069	1064015		NC_000017.11:31258357:TTT:TTTT
NM_001042492.3(NF1):c.284dup (p.Gly96fs)	NF1	G96fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV001073808	17	29486106 - 29486107	17	31159088 - 31159089	1073808	1063890		NC_000017.11:31159088:C:CC
NM_001042492.3(NF1):c.2921dup (p.Asn974fs)	NF1	N974fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV001073717	17	29556921 - 29556922	17	31229903 - 31229904	1073717	1063969		NC_000017.11:31229903:AA:AAA
NM_001042492.3(NF1):c.7644dup (p.Ser2549fs)	NF1	S2528fs, S2549fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001073648	17	29683505 - 29683506	17	31356487 - 31356488	1073648	1064118		NC_000017.11:31356487:A:AA
NM_001042492.3(NF1):c.1726_1727insTTTT (p.Gln576fs)	NF1	Q576fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001073560	17	29550466 - 29550467	17	31223448 - 31223449	1073560	1063932		NC_000017.11:31223448::TTTT
NM_001042492.3(NF1):c.197_198insAGAATGTTAGGCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGCGGATCACGAGGTCAGGAGATCGAGACCATCCTGGCTAACACGGTGAAACCCCGTCTCNNNNNNNNNNAAAAAAAAAAAAAAAAAAAAAA (p.Asn66delinsLysGluCysTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 18, 2020)	criteria provided, single submitter	VCV001073544	17	29483135 - 29483136	17	31156117 - 31156118	1073544	1063888		
NM_001042492.3(NF1):c.2726_2727insTAGGACTACAAATACGGACCAATGTTAAGGATCTGGTTGGTCTAGAATTGAGTCCTGCTC (p.Gly910_Leu911insArgThrThrAsnThrAspGlnCysTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	VCV001073313	17	29556359 - 29556360	17	31229341 - 31229342	1073313	1063965		
NM_001042492.3(NF1):c.7897dup (p.Glu2633fs)	NF1	E2612fs, E2633fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001073171	17	29684313 - 29684314	17	31357295 - 31357296	1073171	1064129		NC_000017.11:31357295:G:GG
NM_001042492.3(NF1):c.8071dup (p.His2691fs)	NF1	H2670fs, H2691fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001073125	17	29685596 - 29685597	17	31358578 - 31358579	1073125	1064132		NC_000017.11:31358578:CC:CCC
NM_001042492.3(NF1):c.2453_2454insGCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGTGGATCACGAGGTCAGGAGATCGAGACCATCCTNNNNNNNNNNAAAAAAAAAAAAGAGGCGAATGTC (p.His819fs)	NF1	H819fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV001073122	17	29556072 - 29556073	17	31229054 - 31229055	1073122	1063958		
NM_001042492.3(NF1):c.7146_7147insTTTTTTTTTTNNNNNNNNNNGGGGTTACACCGAGGTCTCGATCTCCTGACCTCGAGATCCGCACGCCTCGGCCTCCCAAAGAGCTGTGATTAAAGGCGTGAGCCACAGCGACCGGCCGGACTCAATTTC (p.Asn2383delinsPhePhePheXaaXaaXaaXaaGlyLeuHisArgGlyLeuAspLeuLeuThrSerArgSerAlaArgLeuGlyLeuProLysSerCysAspTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV001073014	17	29670098 - 29670099	17	31343080 - 31343081	1073014	1064099		
NM_001042492.3(NF1):c.461_462insA (p.Phe154fs)	NF1	F154fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001072960	17	29490376 - 29490377	17	31163358 - 31163359	1072960	1063895		NC_000017.11:31163358::A
NM_001042492.3(NF1):c.967dup (p.Ala323fs)	NF1	A323fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 23, 2020)	criteria provided, single submitter	VCV001072771	17	29527517 - 29527518	17	31200499 - 31200500	1072771	1063906		NC_000017.11:31200499:G:GG
NM_001042492.3(NF1):c.2036_2043dup (p.Gln682fs)	NF1	Q682fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001072634	17	29553482 - 29553483	17	31226464 - 31226465	1072634	1063940		NC_000017.11:31226464:CCGATTTGCCGA:CCGATTTGCCGATTTGCCGA
NM_001042492.3(NF1):c.5063_5066dup (p.Tyr1689Ter)	NF1	Y1668*, Y1689*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001072598	17	29653064 - 29653065	17	31326046 - 31326047	1072598	1064045		NC_000017.11:31326046:AGTA:AGTAAGTA
NM_001042492.3(NF1):c.1835_1836insAAAAATAAGGTGGCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGNNNNNNNNNNAAAAAAAAAAAAAAAAAAAA (p.Asn614fs)	NF1	N614fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001072491	17	29550575 - 29550576	17	31223557 - 31223558	1072491	1063937		
NM_001042492.3(NF1):c.2082dup (p.Leu695fs)	NF1	L695fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001072489	17	29553530 - 29553531	17	31226512 - 31226513	1072489	1063941		NC_000017.11:31226512:TTT:TTTT
NM_001042492.3(NF1):c.4373_4430+20delinsGCAACTGAGTAAGTGGCAAGAAAATTACCTGCATCAAAGTTGCTTTTCACAAAA	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001071952	17	29586090 - 29586167	17	31259072 - 31259149	1071952	1064021		
NM_001042492.3(NF1):c.1399_1400insAA (p.Thr467fs)	NF1	T467fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001071943	17	29541474 - 29541475	17	31214456 - 31214457	1071943	1063922		NC_000017.11:31214456:A:AAA
NM_001042492.3(NF1):c.192_193insTAA (p.Val65Ter)	NF1	V65*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, single submitter	VCV001071937	17	29483132 - 29483133	17	31156114 - 31156115	1071937	1063887		NC_000017.11:31156114::TAA
NM_001042492.3(NF1):c.7063-1_7087dup	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV001071802	17	29670024 - 29670025	17	31343006 - 31343007	1071802	1064097		NC_000017.11:31343006:AGAGTCCAGAGGAAGTATTTATGGCAA:AGAGTCCAGAGGAAGTATTTATGGCAAGAGTCCAGAGGAAGTATTTATGGCAA
NM_001042492.3(NF1):c.2174_2177dup (p.His729fs)	NF1	H729fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001071683	17	29553624 - 29553625	17	31226606 - 31226607	1071683	1063946		NC_000017.11:31226606:AAGT:AAGTAAGT
NM_001042492.3(NF1):c.4206dup (p.Gly1403fs)	NF1	G1382fs, G1403fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV001071654	17	29585393 - 29585394	17	31258375 - 31258376	1071654	1064016		NC_000017.11:31258375:C:CC
NM_001042492.3(NF1):c.7034dup (p.Leu2345fs)	NF1	L2324fs, L2345fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001071496	17	29667632 - 29667633	17	31340614 - 31340615	1071496	1064096		NC_000017.11:31340614:TTT:TTTT
NM_001042492.3(NF1):c.8202dup (p.Leu2735fs)	NF1	L2714fs, L2735fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2020)	criteria provided, single submitter	VCV001071353	17	29687543 - 29687544	17	31360525 - 31360526	1071353	1064136		NC_000017.11:31360525:TTT:TTTT
NM_001042492.3(NF1):c.7420dup (p.Asp2474fs)	NF1	D2453fs, D2474fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV001071333	17	29677297 - 29677298	17	31350279 - 31350280	1071333	1064110		NC_000017.11:31350279:GG:GGG
NM_001042492.3(NF1):c.662_663dup (p.Asn222fs)	NF1	N222fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001071253	17	29508734 - 29508735	17	31181716 - 31181717	1071253	1063899		NC_000017.11:31181716:GG:GGGG
NM_001042492.3(NF1):c.7178dup (p.His2393fs)	NF1	H2372fs, H2393fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001070994	17	29670141 - 29670142	17	31343123 - 31343124	1070994	1064101		NC_000017.11:31343123:A:AA
NM_001042492.3(NF1):c.3637dup (p.Thr1213fs)	NF1	T1213fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 22, 2020)	criteria provided, single submitter	VCV001070971	17	29560159 - 29560160	17	31233141 - 31233142	1070971	1063999		NC_000017.11:31233141:A:AA
NM_001042492.3(NF1):c.4947dup (p.Pro1650fs)	NF1	P1629fs, P1650fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV001070949	17	29652946 - 29652947	17	31325928 - 31325929	1070949	1064038		NC_000017.11:31325928:GGG:GGGG
NM_001042492.3(NF1):c.6922-7_6925dup	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV001070582	17	29667513 - 29667514	17	31340495 - 31340496	1070582	1064091		NC_000017.11:31340495:CTTTGCCAGGACT:CTTTGCCAGGACTTTGCCAGGACT
NM_001042492.3(NF1):c.7744_7745insCT (p.Gln2582fs)	NF1	Q2561fs, Q2582fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001070474	17	29683983 - 29683984	17	31356965 - 31356966	1070474	1064122		NC_000017.11:31356965::CT
NM_001042492.3(NF1):c.2116dup (p.Ala706fs)	NF1	A706fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV001070397	17	29553566 - 29553567	17	31226548 - 31226549	1070397	1063943		NC_000017.11:31226548:G:GG
NM_001042492.3(NF1):c.1099_1115dup (p.Asp372fs)	NF1	D372fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001070122	17	29528087 - 29528088	17	31201069 - 31201070	1070122	1063911		NC_000017.11:31201069:AGAGGCAGTCAGCCTGCAGA:AGAGGCAGTCAGCCTGCAGAGGCAGTCAGCCTGCAGA
NM_001042492.3(NF1):c.4280dup (p.Leu1427fs)	NF1	L1406fs, L1427fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV001069747	17	29585464 - 29585465	17	31258446 - 31258447	1069747	1064018		NC_000017.11:31258446:TTTT:TTTTT
NM_001042492.3(NF1):c.3887_3888dup (p.Leu1297fs)	NF1	L1297fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 9, 2020)	criteria provided, single submitter	VCV001069529	17	29562950 - 29562951	17	31235932 - 31235933	1069529	1064005		NC_000017.11:31235932:TAT:TATAT
NM_001042492.3(NF1):c.3604_3607dup (p.Asp1203delinsGlyTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV001069318	17	29560124 - 29560125	17	31233106 - 31233107	1069318	1063996		NC_000017.11:31233106:TGGCTG:TGGCTGGCTG
NM_001042492.3(NF1):c.3122dup (p.Met1041fs)	NF1	M1041fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001068930	17	29557867 - 29557868	17	31230849 - 31230850	1068930	1063980		NC_000017.11:31230849:T:TT
NC_000017.10:g.(?_29482991)_(29548957_?)dup	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV001066494	17	29482991 - 29548957			1066494	1054614		
NM_001042492.3(NF1):c.1250_1251insTT (p.Ile418fs)	NF1	I418fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 3, 2021)	criteria provided, single submitter	VCV001064549	17	29528492 - 29528493	17	31201474 - 31201475	1064549	1052790		NC_000017.11:31201474:T:TTT
NM_001042492.3(NF1):c.4247_4248delinsTC (p.Pro1416Leu)	NF1	P1395L, P1416L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001051739	17	29585435 - 29585436	17	31258417 - 31258418	1051739	1050151		NC_000017.11:31258416:CT:TC
NM_001042492.3(NF1):c.2009_2016dup (p.Cys673fs)	NF1	C673fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048750	17	29553459 - 29553460	17	31226441 - 31226442	1048750	1036777		NC_000017.11:31226441:CAGCAGGA:CAGCAGGACAGCAGGA
NM_001042492.3(NF1):c.4432_4433insAA (p.Phe1478Ter)	NF1	F1457*, F1478*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048747	17	29587388 - 29587389	17	31260370 - 31260371	1048747	1036805		NC_000017.11:31260370::AA
NM_001042492.3(NF1):c.4509dup (p.Val1504fs)	NF1	V1483fs, V1504fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048735	17	29587464 - 29587465	17	31260446 - 31260447	1048735	1036806		NC_000017.11:31260446:T:TT
NM_001042492.3(NF1):c.4608_4611delinsC (p.Asp1537del)	NF1	D1516del, D1537del	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048730	17	29588759 - 29588762	17	31261741 - 31261744	1048730	1036810		NC_000017.11:31261740:TGAT:C
NM_001042492.3(NF1):c.2831_2832insAAAA (p.Phe944fs)	NF1	F944fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048728	17	29556464 - 29556465	17	31229446 - 31229447	1048728	1036783		NC_000017.11:31229446::AAAA
NM_001042492.3(NF1):c.2409_2409+4delinsC	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048724	17	29554624 - 29554628	17	31227606 - 31227610	1048724	1036781		NC_000017.11:31227605:GGTAA:C
NM_001042492.3(NF1):c.7788_7789insG (p.Ser2597fs)	NF1	S2576fs, S2597fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048723	17	29684027 - 29684028	17	31357009 - 31357010	1048723	1036839		NC_000017.11:31357009::G
NM_001042492.3(NF1):c.6100dup (p.Thr2034fs)	NF1	T2013fs, T2034fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048717	17	29663443 - 29663444	17	31336425 - 31336426	1048717	1036825		NC_000017.11:31336425:A:AA
NM_001042492.3(NF1):c.3870_3871insTAG (p.Val1291Ter)	NF1	V1291*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048715	17	29562788 - 29562789	17	31235770 - 31235771	1048715	1036801		NC_000017.11:31235770:AG:AGTAG
NM_001042492.3(NF1):c.350dup (p.Cys118fs)	NF1	C118fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048714	17	29490264 - 29490265	17	31163246 - 31163247	1048714	1036761		NC_000017.11:31163246:T:TT
NM_001042492.3(NF1):c.6564dup (p.Pro2189fs)	NF1	P2168fs, P2189fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048708	17	29664521 - 29664522	17	31337503 - 31337504	1048708	1036827		NC_000017.11:31337503:T:TT
NM_001042492.3(NF1):c.1022_1023insGA (p.Ile342fs)	NF1	I342fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048705	17	29527573 - 29527574	17	31200555 - 31200556	1048705	1036770		NC_000017.11:31200555::GA
NM_001042492.3(NF1):c.1691_1692insC (p.Ala565fs)	NF1	A565fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048695	17	29548917 - 29548918	17	31221899 - 31221900	1048695	1036773		NC_000017.11:31221899::C
NM_001042492.3(NF1):c.546dup (p.Ile183fs)	NF1	I183fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048687	17	29496974 - 29496975	17	31169956 - 31169957	1048687	1036765		NC_000017.11:31169956:T:TT
NM_001042492.3(NF1):c.2248dup (p.Thr750fs)	NF1	T750fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048685	17	29553697 - 29553698	17	31226679 - 31226680	1048685	1036780		NC_000017.11:31226679:AA:AAA
NM_001042492.3(NF1):c.3641dup (p.Met1214fs)	NF1	M1214fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048684	17	29560163 - 29560164	17	31233145 - 31233146	1048684	1036797		NC_000017.11:31233145:T:TT
NM_001042492.3(NF1):c.2034_2035insC (p.Ile679fs)	NF1	I679fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048682	17	29553485 - 29553486	17	31226467 - 31226468	1048682	1036778		NC_000017.11:31226467::C
NM_001042492.3(NF1):c.1702_1703dup (p.Thr569fs)	NF1	T569fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048679	17	29548926 - 29548927	17	31221908 - 31221909	1048679	1036774		NC_000017.11:31221908:AGA:AGAGA
NM_001042492.3(NF1):c.1714dup (p.Glu572fs)	NF1	E572fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048677	17	29548937 - 29548938	17	31221919 - 31221920	1048677	1036775		NC_000017.11:31221919:GGG:GGGG
NC_000017.10:g.(?_29422048)_(29510472_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001041200	17	29422048 - 29510472			1041200	1022377		
NM_001042492.3(NF1):c.3173_3174delinsCA (p.Asp1058Ala)	NF1	D1058A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001038352	17	29557919 - 29557920	17	31230901 - 31230902	1038352	1033169		NC_000017.11:31230900:AT:CA
NM_001042492.3(NF1):c.2075_2080dup (p.Tyr692_Met693dup)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 23, 2020)	criteria provided, single submitter	VCV001024366	17	29553522 - 29553523	17	31226504 - 31226505	1024366	1012656		NC_000017.11:31226504:TGTACATGT:TGTACATGTACATGT
NC_000017.10:g.(?_29687495)_(29701173_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001014532	17	29687495 - 29701173			1014532	1001814		
NC_000017.10:g.(?_29679265)_(29701183_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV001006777	17	29679265 - 29701183			1006777	986599		
NC_000017.10:g.(?_29482991)_(29534143_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV001006776	17	29482991 - 29534143			1006776	986598		
NM_001042492.3(NF1):c.3198-5_3198-4dup	NF1		Neurofibromatosis, type 1|not provided	Benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996535	17	29559061 - 29559062	17	31232043 - 31232044	996535	984145		NC_000017.11:31232043:TTTTTTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTTTTTTTT
NM_001042492.3(NF1):c.5731dup (p.Ile1911fs)	NF1	I1890fs, I1911fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996526	17	29657434 - 29657435	17	31330416 - 31330417	996526	984204		NC_000017.11:31330416:A:AA
NM_001042492.3(NF1):c.4185dup (p.Arg1396fs)	NF1	R1375fs, R1396fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996513	17	29585372 - 29585373	17	31258354 - 31258355	996513	984166		NC_000017.11:31258354:G:GG
NM_001042492.3(NF1):c.454dup (p.Ala152fs)	NF1	A152fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996512	17	29490368 - 29490369	17	31163350 - 31163351	996512	984090		NC_000017.11:31163350:G:GG
NM_001042492.3(NF1):c.2072delinsGGGC (p.Leu691delinsArgAla)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996494	17	29553523	17	31226505	996494	984118		NC_000017.11:31226504:T:GGGC
NM_001042492.3(NF1):c.108_111dup (p.His38Ter)	NF1	H38*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996489	17	29483047 - 29483048	17	31156029 - 31156030	996489	984084		NC_000017.11:31156029:TGAG:TGAGTGAG
NM_001042492.3(NF1):c.5852dup (p.Trp1952fs)	NF1	W1931fs, W1952fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996488	17	29661893 - 29661894	17	31334875 - 31334876	996488	984208		NC_000017.11:31334875:CC:CCC
NM_001042492.3(NF1):c.1181_1182dup (p.Lys395fs)	NF1	K395fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996484	17	29528171 - 29528172	17	31201153 - 31201154	996484	984102		NC_000017.11:31201153:TTT:TTTTT
NM_001042492.3(NF1):c.5912_5913dup (p.Thr1972fs)	NF1	T1951fs, T1972fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996481	17	29661954 - 29661955	17	31334936 - 31334937	996481	984209		NC_000017.11:31334936:TT:TTTT
NM_001042492.3(NF1):c.6668delinsTT (p.Cys2223fs)	NF1	C2202fs, C2223fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996479	17	29664862	17	31337844	996479	984219		NC_000017.11:31337843:G:TT
NM_001042492.3(NF1):c.4770_4771delinsT (p.Leu1590fs)	NF1	L1569fs, L1590fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996477	17	29592292 - 29592293	17	31265274 - 31265275	996477	984179		NC_000017.11:31265273:AA:T
NM_001042492.3(NF1):c.7457+1dup	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996469	17	29677335 - 29677336	17	31350317 - 31350318	996469	984239		NC_000017.11:31350317:GG:GGG
NM_001042492.3(NF1):c.4878dup (p.Val1627fs)	NF1	V1606fs, V1627fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996468	17	29652879 - 29652880	17	31325861 - 31325862	996468	984182		NC_000017.11:31325861:T:TT
NM_001042492.3(NF1):c.270_272dup (p.Glu91dup)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996466	17	29486092 - 29486093	17	31159074 - 31159075	996466	984088		NC_000017.11:31159074:GGA:GGAGGA
NM_001042492.3(NF1):c.4193dup (p.Gln1399fs)	NF1	Q1378fs, Q1399fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996464	17	29585378 - 29585379	17	31258360 - 31258361	996464	984167		NC_000017.11:31258360:CCC:CCCC
NM_001042492.3(NF1):c.4903_4917dup (p.Tyr1635_Tyr1639dup)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996454	17	29652894 - 29652895	17	31325876 - 31325877	996454	984184		NC_000017.11:31325876:AAAGCCATATTATGCAAAGCCATAT:AAAGCCATATTATGCAAAGCCATATTATGCAAAGCCATAT
NM_001042492.3(NF1):c.4619_4622delinsAA (p.Ala1540fs)	NF1	A1519fs, A1540fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996443	17	29588770 - 29588773	17	31261752 - 31261755	996443	984175		NC_000017.11:31261751:CAAC:AA
NM_001042492.3(NF1):c.5812+2_5812+3insTA	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996441	17	29657518 - 29657519	17	31330500 - 31330501	996441	984206		NC_000017.11:31330500::TA
NM_001042492.3(NF1):c.5606dup (p.Leu1869fs)	NF1	L1848fs, L1869fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996439	17	29654851 - 29654852	17	31327833 - 31327834	996439	984199		NC_000017.11:31327833:TTT:TTTT
NM_001042492.3(NF1):c.4004dup (p.Asn1335fs)	NF1	N1335fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996437	17	29576027 - 29576028	17	31249009 - 31249010	996437	984160		NC_000017.11:31249009:AAAA:AAAAA
NM_001042492.3(NF1):c.5630dup (p.Cys1878fs)	NF1	C1857fs, C1878fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996433	17	29657333 - 29657334	17	31330315 - 31330316	996433	984201		NC_000017.11:31330315:T:TT
NM_001042492.3(NF1):c.6989dup (p.Leu2330fs)	NF1	L2309fs, L2330fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996429	17	29667588 - 29667589	17	31340570 - 31340571	996429	984228		NC_000017.11:31340570:TT:TTT
NM_001042492.3(NF1):c.4835+3_4835+10delinsT	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996410	17	29592360 - 29592367	17	31265342 - 31265349	996410	984181		NC_000017.11:31265341:AAGAAATA:T
NM_001042492.3(NF1):c.5236dup (p.Leu1746fs)	NF1	L1725fs, L1746fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996404	17	29653237 - 29653238	17	31326219 - 31326220	996404	984187		NC_000017.11:31326219:C:CC
NM_001042492.3(NF1):c.2855_2856insG (p.Leu953fs)	NF1	L953fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996403	17	29556857 - 29556858	17	31229839 - 31229840	996403	984128		NC_000017.11:31229839::G
NM_001042492.3(NF1):c.6994_6995delinsATTT (p.Ser2332fs)	NF1	S2311fs, S2332fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996393	17	29667595 - 29667596	17	31340577 - 31340578	996393	984229		NC_000017.11:31340576:TC:ATTT
NM_001042492.3(NF1):c.3063_3067dup (p.Met1023delinsLysTer)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996389	17	29557349 - 29557350	17	31230331 - 31230332	996389	984135		NC_000017.11:31230331:AATGA:AATGAAATGA
NM_001042492.3(NF1):c.4099_4108dup (p.Gln1370fs)	NF1	Q1370fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996386	17	29576124 - 29576125	17	31249106 - 31249107	996386	984164		NC_000017.11:31249106:CTGTTTATACC:CTGTTTATACCTGTTTATACC
NM_001042492.3(NF1):c.1372_1373delinsG (p.Pro458fs)	NF1	P458fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996383	17	29533369 - 29533370	17	31206351 - 31206352	996383	984106		NC_000017.11:31206350:CC:G
NM_001042492.3(NF1):c.339dup (p.Leu114fs)	NF1	L114fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996382	17	29490253 - 29490254	17	31163235 - 31163236	996382	984089		NC_000017.11:31163235:G:GG
NM_001042492.3(NF1):c.5582dup (p.Asn1861fs)	NF1	N1840fs, N1861fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996381	17	29654828 - 29654829	17	31327810 - 31327811	996381	984198		NC_000017.11:31327810:AA:AAA
NM_001042492.3(NF1):c.1895dup (p.Cys632fs)	NF1	C632fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996380	17	29552161 - 29552162	17	31225143 - 31225144	996380	984114		NC_000017.11:31225143:G:GG
NM_001042492.3(NF1):c.3232dup (p.Ser1078fs)	NF1	S1078fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000995899	17	29559122 - 29559123	17	31232104 - 31232105	995899	983605		NC_000017.11:31232104:TTT:TTTT
NM_001042492.3(NF1):c.4883dup (p.Leu1628fs)	NF1	L1607fs, L1628fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, single submitter	VCV000995898	17	29652883 - 29652884	17	31325865 - 31325866	995898	983607		NC_000017.11:31325865:TT:TTT
NM_001042492.3(NF1):c.6081_6083delinsGG (p.Ala2028fs)	NF1	A2028fs, A2007fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000971989	17	29663425 - 29663427	17	31336407 - 31336409	971989	958065		NC_000017.11:31336406:AGC:GG
NM_001042492.3(NF1):c.1296delinsATA (p.Cys434fs)	NF1	C434fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000971041	17	29533293	17	31206275	971041	958028		NC_000017.11:31206274:G:ATA
NM_001042492.3(NF1):c.2229dup (p.Val744fs)	NF1	V744fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV000968211	17	29553679 - 29553680	17	31226661 - 31226662	968211	958039		NC_000017.11:31226661:T:TT
NM_001042492.3(NF1):c.7753dup (p.Ser2585fs)	NF1	S2585fs, S2564fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000967735	17	29683989 - 29683990	17	31356971 - 31356972	967735	958079		NC_000017.11:31356971:TTT:TTTT
NM_001042492.3(NF1):c.4980_4981insTT (p.Lys1661fs)	NF1	K1640fs, K1661fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000965959	17	29652981 - 29652982	17	31325963 - 31325964	965959	958055		NC_000017.11:31325963:T:TTT
NM_001042492.3(NF1):c.2521_2524dup (p.Gly842fs)	NF1	G842fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000965882	17	29556151 - 29556152	17	31229133 - 31229134	965882	958041		NC_000017.11:31229133:TGACTG:TGACTGACTG
NM_001042492.3(NF1):c.5199_5230delinsTGCT (p.Leu1733fs)	NF1	L1733fs, L1712fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000965757	17	29653201 - 29653232	17	31326183 - 31326214	965757	958060		NC_000017.11:31326182:AGAAGAGGACCTGAAGGTATTCCACAATGCTC:TGCT
NM_001042492.3(NF1):c.7458_7462delinsTCT (p.Arg2486fs)	NF1	R2465fs, R2486fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000965641	17	29679275 - 29679279	17	31352257 - 31352261	965641	958077		NC_000017.11:31352256:GACAC:TCT
NM_001042492.3(NF1):c.205-11_205-6delinsGGAAAA	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000965529	17	29486017 - 29486022	17	31158999 - 31159004	965529	960875		NC_000017.11:31158998:TTTTCT:GGAAAA
NM_001042492.3(NF1):c.1261_1268delinsCCC (p.Ser421fs)	NF1	S421fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000965468	17	29533258 - 29533265	17	31206240 - 31206247	965468	958026		NC_000017.11:31206239:TCCGCATT:CCC
NM_001042492.3(NF1):c.6823_6827delinsTGG (p.Leu2275fs)	NF1	L2254fs, L2275fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000965365	17	29665725 - 29665729	17	31338707 - 31338711	965365	958069		NC_000017.11:31338706:CTTGA:TGG
NM_001042492.3(NF1):c.3818_3819delinsGA (p.Thr1273Arg)	NF1	T1273R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000964241	17	29562738 - 29562739	17	31235720 - 31235721	964241	949803		NC_000017.11:31235719:CT:GA
NM_001042492.3(NF1):c.6925dup (p.Ser2309fs)	NF1	S2288fs, S2309fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000962768	17	29667525 - 29667526	17	31340507 - 31340508	962768	949853		NC_000017.11:31340507:T:TT
NM_001042492.3(NF1):c.6105dup (p.Val2036fs)	NF1	V2036fs, V2015fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000961848	17	29663448 - 29663449	17	31336430 - 31336431	961848	949838		NC_000017.11:31336430:T:TT
NM_001042492.3(NF1):c.3140_3142dup (p.Trp1048_Val1049insTyr)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV000959553	17	29557885 - 29557886	17	31230867 - 31230868	959553	949793		NC_000017.11:31230867:ACT:ACTACT
NM_001042492.3(NF1):c.4621_4622insG (p.Thr1541fs)	NF1	T1520fs, T1541fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV000959235	17	29588772 - 29588773	17	31261754 - 31261755	959235	949816		NC_000017.11:31261754::G
NM_001042492.3(NF1):c.5672_5673insAA (p.Leu1892fs)	NF1	L1871fs, L1892fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 17, 2019)	criteria provided, single submitter	VCV000957518	17	29657375 - 29657376	17	31330357 - 31330358	957518	949828		NC_000017.11:31330357:A:AAA
NM_001042492.3(NF1):c.2539dup (p.Leu847fs)	NF1	L847fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000957401	17	29556169 - 29556170	17	31229151 - 31229152	957401	949789		NC_000017.11:31229151:CCC:CCCC
NM_001042492.3(NF1):c.5886dup (p.Asn1963Ter)	NF1	N1942*, N1963*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000957335	17	29661928 - 29661929	17	31334910 - 31334911	957335	949833		NC_000017.11:31334910:T:TT
NM_001042492.3(NF1):c.4252_4253insCAA (p.Ile1418_Val1419insThr)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000955747	17	29585439 - 29585440	17	31258421 - 31258422	955747	949811		NC_000017.11:31258421:A:ACAA
NM_001042492.3(NF1):c.5958dup (p.Gln1987fs)	NF1	Q1966fs, Q1987fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000954630	17	29661996 - 29661997	17	31334978 - 31334979	954630	949835		NC_000017.11:31334978:AAAAA:AAAAAA
NM_001042492.3(NF1):c.1097dup (p.Gly367fs)	NF1	G367fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000954600	17	29528088 - 29528089	17	31201070 - 31201071	954600	949766		NC_000017.11:31201070:G:GG
NM_001042492.3(NF1):c.3198-4_3198-3insGT	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 10, 2020)	criteria provided, single submitter	VCV000954167	17	29559086 - 29559087	17	31232068 - 31232069	954167	960202		NC_000017.11:31232068:T:TGT
NM_001042492.3(NF1):c.5609_5609+1delinsAA	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000953772	17	29654857 - 29654858	17	31327839 - 31327840	953772	960208		NC_000017.11:31327838:GG:AA
NM_001042492.3(NF1):c.2724dup (p.Val909fs)	NF1	V909fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000952769	17	29556354 - 29556355	17	31229336 - 31229337	952769	928134		NC_000017.11:31229336:AAA:AAAA
NM_001042492.3(NF1):c.1348_1349dup (p.Val451fs)	NF1	V451fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000952696	17	29533344 - 29533345	17	31206326 - 31206327	952696	928112		NC_000017.11:31206326:GC:GCGC
NM_001042492.3(NF1):c.2748dup (p.Val917fs)	NF1	V917fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000952281	17	29556380 - 29556381	17	31229362 - 31229363	952281	928135		NC_000017.11:31229362:T:TT
NM_001042492.3(NF1):c.7151_7152insA (p.Ser2384_Asn2385insTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000950706	17	29670115 - 29670116	17	31343097 - 31343098	950706	928204		NC_000017.11:31343097::A
NM_001042492.3(NF1):c.3270_3271insC (p.Asp1091fs)	NF1	D1091fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000950403	17	29559163 - 29559164	17	31232145 - 31232146	950403	928142		NC_000017.11:31232145::C
NM_001042492.3(NF1):c.7131dup (p.Val2378fs)	NF1	V2357fs, V2378fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000949551	17	29670091 - 29670092	17	31343073 - 31343074	949551	928203		NC_000017.11:31343073:TTTT:TTTTT
NM_001042492.3(NF1):c.7039dup (p.Ser2347fs)	NF1	S2326fs, S2347fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000948881	17	29667639 - 29667640	17	31340621 - 31340622	948881	928200		NC_000017.11:31340621:A:AA
NM_001042492.3(NF1):c.4051dup (p.Ile1351fs)	NF1	I1351fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV000948755	17	29576077 - 29576078	17	31249059 - 31249060	948755	928159		NC_000017.11:31249059:A:AA
NM_001042492.3(NF1):c.820_823dup (p.Ile275fs)	NF1	I275fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 6, 2019)	criteria provided, single submitter	VCV000948604	17	29509614 - 29509615	17	31182596 - 31182597	948604	928101		NC_000017.11:31182596:CTTA:CTTACTTA
NM_001042492.3(NF1):c.6979dup (p.Glu2327fs)	NF1	E2327fs, E2306fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 30, 2020)	criteria provided, single submitter	VCV000947494	17	29667579 - 29667580	17	31340561 - 31340562	947494	928199		NC_000017.11:31340561:G:GG
NM_001042492.3(NF1):c.2319dup (p.Thr774fs)	NF1	T774fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000947265	17	29554302 - 29554303	17	31227284 - 31227285	947265	928126		NC_000017.11:31227284:C:CC
NM_001042492.3(NF1):c.5767dup (p.Thr1923fs)	NF1	T1902fs, T1923fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 2, 2020)	criteria provided, single submitter	VCV000947174	17	29657470 - 29657471	17	31330452 - 31330453	947174	928182		NC_000017.11:31330452:A:AA
NM_001042492.3(NF1):c.7989_7990insTT (p.Lys2664fs)	NF1	K2664fs, K2643fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000946185	17	29685515 - 29685516	17	31358497 - 31358498	946185	928216		NC_000017.11:31358497:T:TTT
NM_001042492.3(NF1):c.1946_1950dup (p.Leu651fs)	NF1	L651fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000945149	17	29552212 - 29552213	17	31225194 - 31225195	945149	928120		NC_000017.11:31225194:AATTA:AATTAAATTA
NM_001042492.3(NF1):c.1062+2dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000944885	17	29527614 - 29527615	17	31200596 - 31200597	944885	941166		NC_000017.11:31200596:T:TT
NM_001042492.3(NF1):c.540dup (p.Gln181fs)	NF1	Q181fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000944255	17	29496968 - 29496969	17	31169950 - 31169951	944255	928096		NC_000017.11:31169950:A:AA
NM_001042492.3(NF1):c.3866dup (p.Lys1290fs)	NF1	K1290fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000943914	17	29562783 - 29562784	17	31235765 - 31235766	943914	937819		NC_000017.11:31235765:TTT:TTTT
NM_001042492.3(NF1):c.2034_2035delinsAG (p.Ile679Val)	NF1	I679V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV000943898	17	29553485 - 29553486	17	31226467 - 31226468	943898	937780		NC_000017.11:31226466:GA:AG
NM_001042492.3(NF1):c.2350_2378dup (p.Tyr794_Pro795insGlyAsnLysGlnGlnSerTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000943772	17	29554562 - 29554563	17	31227544 - 31227545	943772	937785		NC_000017.11:31227544:AATGGGAACAAGCAACAAAGCTAATCCTTAA:AATGGGAACAAGCAACAAAGCTAATCCTTAATGGGAACAAGCAACAAAGCTAATCCTTAA
NM_001042492.3(NF1):c.4860dup (p.Asp1621Ter)	NF1	D1600*, D1621*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 30, 2019)	criteria provided, single submitter	VCV000943267	17	29652861 - 29652862	17	31325843 - 31325844	943267	937840		NC_000017.11:31325843:T:TT
NM_001042492.3(NF1):c.3658_3659insTTTG (p.Glu1220delinsValTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000942889	17	29560180 - 29560181	17	31233162 - 31233163	942889	937812		NC_000017.11:31233162:G:GTTTG
NM_001042492.3(NF1):c.2800_2801insGT (p.Phe934fs)	NF1	F934fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000941112	17	29556432 - 29556433	17	31229414 - 31229415	941112	937791		NC_000017.11:31229414:T:TGT
NM_001042492.3(NF1):c.4796_4797insG (p.Lys1600fs)	NF1	K1579fs, K1600fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000940639	17	29592318 - 29592319	17	31265300 - 31265301	940639	937838		NC_000017.11:31265300::G
NM_001042492.3(NF1):c.2891_2892delinsAG (p.Thr964Lys)	NF1	T964K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000940258	17	29556893 - 29556894	17	31229875 - 31229876	940258	937794		NC_000017.11:31229874:CC:AG
NM_001042492.3(NF1):c.2439_2440insG (p.Lys814fs)	NF1	K814fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 27, 2019)	criteria provided, single submitter	VCV000939785	17	29556072 - 29556073	17	31229054 - 31229055	939785	937788		NC_000017.11:31229054::G
NM_001042492.3(NF1):c.2835dup (p.Asp946Ter)	NF1	D946*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 22, 2020)	criteria provided, single submitter	VCV000939599	17	29556462 - 29556463	17	31229444 - 31229445	939599	937792		NC_000017.11:31229444:TTTTTT:TTTTTTT
NM_001042492.3(NF1):c.7788_7789dup (p.Ser2597fs)	NF1	S2597fs, S2576fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000939126	17	29684025 - 29684026	17	31357007 - 31357008	939126	937877		NC_000017.11:31357007:TTT:TTTTT
NM_001042492.3(NF1):c.3505dup (p.Tyr1169fs)	NF1	Y1169fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000939099	17	29560026 - 29560027	17	31233008 - 31233009	939099	937807		NC_000017.11:31233008:TT:TTT
NM_001042492.3(NF1):c.56AGC[3] (p.Gln20dup)	NF1|LOC111811965		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000939095	17	29422382 - 29422383	17	31095364 - 31095365	939095	940389		NC_000017.11:31095364:AGCAG:AGCAGCAG
NM_001042492.3(NF1):c.3873_3875dup (p.Tyr1292Ter)	NF1	Y1292*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000938894	17	29562937 - 29562938	17	31235919 - 31235920	938894	937820		NC_000017.11:31235919:ATA:ATAATA
NM_001042492.3(NF1):c.4176_4177insT (p.Val1393fs)	NF1	V1372fs, V1393fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000938607	17	29585364 - 29585365	17	31258346 - 31258347	938607	937825		NC_000017.11:31258346::T
NM_001042492.3(NF1):c.8124dup (p.Asn2709Ter)	NF1	N2688*, N2709*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000937833	17	29685993 - 29685994	17	31358975 - 31358976	937833	937880		NC_000017.11:31358975:TTTT:TTTTT
NM_001042492.3(NF1):c.1346_1347dup (p.Ala450fs)	NF1	A450fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000937286	17	29533341 - 29533342	17	31206323 - 31206324	937286	937777		NC_000017.11:31206323:AAA:AAAAA
NM_001042492.3(NF1):c.851_854dup (p.Lys286fs)	NF1	K286fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000937166	17	29509645 - 29509646	17	31182627 - 31182628	937166	937769		NC_000017.11:31182627:TATC:TATCTATC
NM_001042492.3(NF1):c.5733_5734delinsAC (p.Ser1912Arg)	NF1	S1912R, S1891R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000937079	17	29657437 - 29657438	17	31330419 - 31330420	937079	937853		NC_000017.11:31330418:TA:AC
NM_001042492.3(NF1):c.2353dup (p.Glu785fs)	NF1	E785fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV000936941	17	29554565 - 29554566	17	31227547 - 31227548	936941	937786		NC_000017.11:31227547:GGG:GGGG
NM_001042492.3(NF1):c.944_945insTGCC (p.Gln315fs)	NF1	Q315fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000936575	17	29527495 - 29527496	17	31200477 - 31200478	936575	937770		NC_000017.11:31200477::TGCC
NM_001042492.3(NF1):c.630dup (p.Ala211fs)	NF1	A211fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000935173	17	29508482 - 29508483	17	31181464 - 31181465	935173	937766		NC_000017.11:31181464:A:AA
NM_001042492.3(NF1):c.5914dup (p.Thr1972fs)	NF1	T1972fs, T1951fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000931387	17	29661956 - 29661957	17	31334938 - 31334939	931387	919723		NC_000017.11:31334938:A:AA
NM_001042492.3(NF1):c.6705-7_6705-6insAAAA	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000873036	17	29665034 - 29665035	17	31338016 - 31338017	873036	861166		NC_000017.11:31338016:AA:AAAAAA
NM_001042492.3(NF1):c.7602dup (p.Lys2535Ter)	NF1	K2535*, K2514*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000872187	17	29679418 - 29679419	17	31352400 - 31352401	872187	860374		NC_000017.11:31352400:T:TT
Single allele	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000870261					870261	858433		
Single allele	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 7, 2019)	criteria provided, single submitter	VCV000870257					870257	858429		
NM_001042492.3(NF1):c.1836_1837insSVAelement	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000870246	17	29550576 - 29550577	17	31223558 - 31223559	870246	858415		
NM_001042492.3(NF1):c.3786_3787insSVAelement	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000870241	17	29562706 - 29562707	17	31235688 - 31235689	870241	858416		
NM_001042492.3(NF1):c.7212dup (p.Ile2405fs)	NF1	I2405fs, I2384fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV000864530	17	29676159 - 29676160	17	31349141 - 31349142	864530	845145		NC_000017.11:31349141:T:TT
NM_001042492.3(NF1):c.2369_2370dup (p.Ile791Ter)	NF1	I791*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000864452	17	29554583 - 29554584	17	31227565 - 31227566	864452	844943		NC_000017.11:31227565:TA:TATA
NM_001042492.3(NF1):c.7247_7250dup (p.Leu2419fs)	NF1	L2419fs, L2398fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 9, 2019)	criteria provided, single submitter	VCV000864134	17	29676194 - 29676195	17	31349176 - 31349177	864134	845149		NC_000017.11:31349176:TACT:TACTTACT
NM_001042492.3(NF1):c.5629dup (p.Leu1877fs)	NF1	L1877fs, L1856fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000864001	17	29657332 - 29657333	17	31330314 - 31330315	864001	845076		NC_000017.11:31330314:C:CC
NM_001042492.3(NF1):c.439_445dup (p.Asn149fs)	NF1	N149fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000863925	17	29490353 - 29490354	17	31163335 - 31163336	863925	844863		NC_000017.11:31163335:TGCAACA:TGCAACATGCAACA
NM_001042492.3(NF1):c.6186_6187insG (p.Leu2063fs)	NF1	L2063fs, L2042fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000863626	17	29663691 - 29663692	17	31336673 - 31336674	863626	845094		NC_000017.11:31336673::G
NM_001042492.3(NF1):c.4275dup (p.Ile1426fs)	NF1	I1426fs, I1405fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000863229	17	29585460 - 29585461	17	31258442 - 31258443	863229	845032		NC_000017.11:31258442:GGG:GGGG
NM_001042492.3(NF1):c.1260+2_1260+3insTT	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000862880	17	29528504 - 29528505	17	31201486 - 31201487	862880	852169		NC_000017.11:31201486:T:TTT
NM_001042492.3(NF1):c.393_394delinsCC (p.Ala132Pro)	NF1	A132P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV000861399	17	29490308 - 29490309	17	31163290 - 31163291	861399	844857		NC_000017.11:31163289:AG:CC
NM_001042492.3(NF1):c.5639dup (p.Leu1880fs)	NF1	L1859fs, L1880fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000861337	17	29657341 - 29657342	17	31330323 - 31330324	861337	845077		NC_000017.11:31330323:TT:TTT
NM_001042492.3(NF1):c.7184dup (p.Leu2395fs)	NF1	L2374fs, L2395fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000861173	17	29670144 - 29670145	17	31343126 - 31343127	861173	845144		NC_000017.11:31343126:TTTT:TTTTT
NM_001042492.3(NF1):c.7453dup (p.Tyr2485fs)	NF1	Y2464fs, Y2485fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 6, 2019)	criteria provided, single submitter	VCV000860235	17	29677331 - 29677332	17	31350313 - 31350314	860235	845161		NC_000017.11:31350313:T:TT
NM_001042492.3(NF1):c.7120dup (p.Met2374fs)	NF1	M2374fs, M2353fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000860110	17	29670081 - 29670082	17	31343063 - 31343064	860110	845137		NC_000017.11:31343063:AAA:AAAA
NM_001042492.3(NF1):c.6307dup (p.Leu2103fs)	NF1	L2082fs, L2103fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000859025	17	29663810 - 29663811	17	31336792 - 31336793	859025	845098		NC_000017.11:31336792:CC:CCC
NM_001042492.3(NF1):c.7495_7496delinsCT (p.Gly2499Leu)	NF1	G2478L, G2499L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000858928	17	29679312 - 29679313	17	31352294 - 31352295	858928	845166		NC_000017.11:31352293:GG:CT
NM_001042492.3(NF1):c.1564dup (p.Thr522fs)	NF1	T522fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, single submitter	VCV000858595	17	29546058 - 29546059	17	31219040 - 31219041	858595	844906		NC_000017.11:31219040:A:AA
NM_001042492.3(NF1):c.5328_5329delinsTA (p.Val1777Ile)	NF1	V1777I, V1756I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000856337	17	29654576 - 29654577	17	31327558 - 31327559	856337	845062		NC_000017.11:31327557:AG:TA
NM_001042492.3(NF1):c.4521dup (p.His1508fs)	NF1	H1487fs, H1508fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000856053	17	29587476 - 29587477	17	31260458 - 31260459	856053	845043		NC_000017.11:31260458:A:AA
NM_001042492.3(NF1):c.7573_7574insT (p.Asp2525fs)	NF1	D2525fs, D2504fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000855778	17	29679390 - 29679391	17	31352372 - 31352373	855778	845171		NC_000017.11:31352372::T
NM_001042492.3(NF1):c.4340_4341delinsCA (p.Gln1447Pro)	NF1	Q1447P, Q1426P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000854788	17	29586057 - 29586058	17	31259039 - 31259040	854788	845035		NC_000017.11:31259038:AG:CA
NM_001042492.3(NF1):c.2249_2251+4dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000853676	17	29553697 - 29553698	17	31226679 - 31226680	853676	852861		NC_000017.11:31226679:AACAGGTAA:AACAGGTAACAGGTAA
NM_001042492.3(NF1):c.7157_7158dup (p.Asn2387fs)	NF1	N2366fs, N2387fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000851908	17	29670119 - 29670120	17	31343101 - 31343102	851908	845140		NC_000017.11:31343101:TTT:TTTTT
NM_001042492.3(NF1):c.1896dup (p.Asp633Ter)	NF1	D633*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000851537	17	29552162 - 29552163	17	31225144 - 31225145	851537	844922		NC_000017.11:31225144:T:TT
NM_001042492.3(NF1):c.6892dup (p.Leu2298fs)	NF1	L2298fs, L2277fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000851532	17	29665793 - 29665794	17	31338775 - 31338776	851532	845125		NC_000017.11:31338775:C:CC
NM_001042492.3(NF1):c.998dup (p.Tyr333Ter)	NF1	Y333*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000850603	17	29527548 - 29527549	17	31200530 - 31200531	850603	844884		NC_000017.11:31200530:A:AA
NM_001042492.3(NF1):c.6705-9_6705-8insGCAGATTG	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000849609	17	29665034 - 29665035	17	31338016 - 31338017	849609	851707		NC_000017.11:31338016::GCAGATTG
NM_001042492.3(NF1):c.1639dup (p.Glu547fs)	NF1	E547fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000848456	17	29546132 - 29546133	17	31219114 - 31219115	848456	844911		NC_000017.11:31219114:GG:GGG
NM_001042492.3(NF1):c.2546dup (p.Val850fs)	NF1	V850fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000848118	17	29556174 - 29556175	17	31229156 - 31229157	848118	844946		NC_000017.11:31229156:GGGGG:GGGGGG
NM_001042492.3(NF1):c.1759_1760insTAGTT (p.Ser587fs)	NF1	S587fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 16, 2019)	criteria provided, single submitter	VCV000848008	17	29550499 - 29550500	17	31223481 - 31223482	848008	844916		NC_000017.11:31223481::TAGTT
NM_001042492.3(NF1):c.7059_7062dup (p.Ser2355fs)	NF1	S2355fs, S2334fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000846444	17	29667659 - 29667660	17	31340641 - 31340642	846444	845133		NC_000017.11:31340641:CAAG:CAAGCAAG
NM_001042492.3(NF1):c.7534_7537dup (p.Gln2513fs)	NF1	Q2513fs, Q2492fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000846377	17	29679349 - 29679350	17	31352331 - 31352332	846377	845169		NC_000017.11:31352331:CGGCC:CGGCCGGCC
NM_001042492.3(NF1):c.4577+2dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000846370	17	29587534 - 29587535	17	31260516 - 31260517	846370	851703		NC_000017.11:31260516:T:TT
NM_001042492.3(NF1):c.1849_1850delinsTA (p.Ala617Ter)	NF1	A617*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000846124	17	29552116 - 29552117	17	31225098 - 31225099	846124	844919		NC_000017.11:31225097:GC:TA
NM_001042492.3(NF1):c.3380dup (p.Gly1128fs)	NF1	G1128fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000844681	17	29559782 - 29559783	17	31232764 - 31232765	844681	844988		NC_000017.11:31232764:C:CC
NM_001042492.3(NF1):c.4076dup (p.Gln1360fs)	NF1	Q1360fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000844453	17	29576097 - 29576098	17	31249079 - 31249080	844453	845022		NC_000017.11:31249079:CCCCCC:CCCCCCC
NM_001042492.3(NF1):c.4211_4213dup (p.Ala1404dup)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000844325	17	29585397 - 29585398	17	31258379 - 31258380	844325	845025		NC_000017.11:31258379:GCAG:GCAGCAG
NM_001042492.3(NF1):c.6322dup (p.Thr2108fs)	NF1	T2108fs, T2087fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000844156	17	29663826 - 29663827	17	31336808 - 31336809	844156	845099		NC_000017.11:31336808:A:AA
NM_001042492.3(NF1):c.5521dup (p.Gln1841fs)	NF1	Q1820fs, Q1841fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000842214	17	29654764 - 29654765	17	31327746 - 31327747	842214	845068		NC_000017.11:31327746:CCCCC:CCCCCC
NM_001042492.3(NF1):c.1103dup (p.Ser368fs)	NF1	S368fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000841815	17	29528094 - 29528095	17	31201076 - 31201077	841815	844888		NC_000017.11:31201076:G:GG
NM_001042492.3(NF1):c.7142dup (p.Asn2381fs)	NF1	N2381fs, N2360fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000839973	17	29670104 - 29670105	17	31343086 - 31343087	839973	845139		NC_000017.11:31343086:AA:AAA
NM_001042492.3(NF1):c.6524_6525insAA (p.Ile2176fs)	NF1	I2176fs, I2155fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000839327	17	29664482 - 29664483	17	31337464 - 31337465	839327	845112		NC_000017.11:31337464::AA
NM_001042492.3(NF1):c.2900dup (p.Met968fs)	NF1	M968fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV000839014	17	29556901 - 29556902	17	31229883 - 31229884	839014	844963		NC_000017.11:31229883:T:TT
NM_001042492.3(NF1):c.3447_3448delinsTG (p.Met1149_Ser1150delinsIleAla)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000838458	17	29559850 - 29559851	17	31232832 - 31232833	838458	844991		NC_000017.11:31232831:GT:TG
NM_001042492.3(NF1):c.1721+3dup	NF1	Y575*	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV000837851	17	29548949 - 29548950	17	31221931 - 31221932	837851	852859		NC_000017.11:31221931:A:AA
NM_001042492.3(NF1):c.2596_2600dup (p.Met867fs)	NF1	M867fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000837844	17	29556228 - 29556229	17	31229210 - 31229211	837844	844949		NC_000017.11:31229210:CCCAT:CCCATCCCAT
NM_001042492.3(NF1):c.3207_3208delinsTT (p.Gln1070Ter)	NF1	Q1070*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV000835546	17	29559100 - 29559101	17	31232082 - 31232083	835546	844980		NC_000017.11:31232081:CC:TT
NM_001042492.3(NF1):c.997dup (p.Tyr333fs)	NF1	Y333fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000834888	17	29527546 - 29527547	17	31200528 - 31200529	834888	844883		NC_000017.11:31200528:TT:TTT
NC_000017.11:g.(?_31155973)_(31297359_?)dup	NF1|OMG		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV000833022	17	29482991 - 29624377			833022	821005		
NC_000017.11:g.(?_31374003)_(31374155_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000832917	17	29701021 - 29701173			832917	821034		
NC_000017.11:g.(?_31159000)_(31182675_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000832278	17	29486018 - 29509693			832278	821006		
NC_000017.11:g.(?_31155973)_(31265349_?)dup	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 2, 2019)	criteria provided, single submitter	VCV000831854	17	29482991 - 29592367			831854	821004		
NC_000017.11:g.(?_31169881)_(31249129_?)dup	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000831826	17	29496899 - 29576147			831826	821010		
NC_000017.11:g.(?_31169881)_(31236031_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000831353	17	29496899 - 29563049			831353	821009		
NC_000017.11:g.(?_31095300)_(31265349_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000830461	17	29422318 - 29592367			830461	821002		
NC_000017.11:g.(?_31095030)_(31104404_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000830450	17	29422048 - 29431422			830450	820996		
NM_001042492.3(NF1):c.1182dup (p.Lys395Ter)	NF1	K395*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000818520	17	29528171 - 29528172	17	31201153 - 31201154	818520	813128	rs1597682159	NC_000017.11:31201153:TTT:TTTT
NM_001042492.3(NF1):c.5199dup (p.Glu1734fs)	NF1	E1713fs, E1734fs	Tibial pseudoarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818195	17	29653200 - 29653201	17	31326182 - 31326183	818195	806398	rs1597830232	NC_000017.11:31326182:A:AA
NM_001042492.3(NF1):c.5046delinsGGTTAC (p.Cys1682fs)	NF1	C1661fs, C1682fs	Tibial pseudoarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818193	17	29653048	17	31326030	818193	806396	rs1597829913	NC_000017.11:31326029:T:GGTTAC
NM_001042492.3(NF1):c.3187_3188insTA (p.Cys1063fs)	NF1	C1063fs	Tibial pseudoarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818191	17	29557933 - 29557934	17	31230915 - 31230916	818191	806394	rs1597717684	NC_000017.11:31230915::TA
NM_001042492.3(NF1):c.1992dup (p.Ser665fs)	NF1	S665fs	Tibial pseudoarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818184	17	29552258 - 29552259	17	31225240 - 31225241	818184	806390	rs1597710824	NC_000017.11:31225240:C:CC
NM_001042492.3(NF1):c.786_787insTT (p.Lys263fs)	NF1	K263fs	Tibial pseudoarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818182	17	29509580 - 29509581	17	31182562 - 31182563	818182	806388	rs1597659879	NC_000017.11:31182562:T:TTT
NM_001042492.3(NF1):c.1608dup (p.His537fs)	NF1	H537fs	not provided	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000817295	17	29546102 - 29546103	17	31219084 - 31219085	817295	805936	rs1597703530	NC_000017.11:31219084:A:AA
NM_001042492.3(NF1):c.1399dup (p.Thr467fs)	NF1	T467fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000817038	17	29541474 - 29541475	17	31214456 - 31214457	817038	805935	rs778963145	NC_000017.11:31214456:A:AA
NM_001042492.3(NF1):c.7870-24_7870-19delinsTTTTAG	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816749	17	29684263 - 29684268	17	31357245 - 31357250	816749	804978	rs1597866743	NC_000017.11:31357244:GTTTAC:TTTTAG
NM_001042492.3(NF1):c.1722-8_1722-3delinsAAAA	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816745	17	29550454 - 29550459	17	31223436 - 31223441	816745	804941	rs1597708581	NC_000017.11:31223435:TACTGC:AAAA
NM_001042492.3(NF1):c.792dup (p.Ala265fs)	NF1	A265fs	not specified	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000811981	17	29509586 - 29509587	17	31182568 - 31182569	811981	800010	rs1597659896	NC_000017.11:31182568:A:AA
NM_001042492.3(NF1):c.3217_3218delinsTTCC (p.Met1073fs)	NF1	M1073fs	not specified	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000811815	17	29559110 - 29559111	17	31232092 - 31232093	811815	800014	rs1597718755	NC_000017.11:31232091:AT:TTCC
NM_001042492.3(NF1):c.7090dup (p.Arg2364fs)	NF1	R2343fs, R2364fs	not specified	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000811261	17	29670052 - 29670053	17	31343034 - 31343035	811261	800024	rs1597851299	NC_000017.11:31343034:CC:CCC
NM_001042492.3(NF1):c.7724_7725dup (p.Asp2576fs)	NF1	D2555fs, D2576fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803377	17	29683585 - 29683586	17	31356567 - 31356568	803377	791730	rs1597865858	NC_000017.11:31356567:CT:CTCT
NM_001042492.3(NF1):c.6360_6363dup (p.Thr2122fs)	NF1	T2101fs, T2122fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803372	17	29663863 - 29663864	17	31336845 - 31336846	803372	791725	rs1597843096	NC_000017.11:31336845:CTTCC:CTTCCTTCC
NM_001042492.3(NF1):c.5814_5815insTTTTT (p.Ile1939fs)	NF1	I1918fs, I1939fs	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803369	17	29661856 - 29661857	17	31334838 - 31334839	803369	791722	rs1481408918	NC_000017.11:31334838:T:TTTTTT
NM_001042492.3(NF1):c.5379_5380dup (p.Val1794fs)	NF1	V1794fs, V1773fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803367	17	29654626 - 29654627	17	31327608 - 31327609	803367	791720	rs1597832021	NC_000017.11:31327608:AG:AGAG
NM_001042492.3(NF1):c.5046dup (p.Asn1683Ter)	NF1	N1662*, N1683*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803365	17	29653047 - 29653048	17	31326029 - 31326030	803365	791718	rs1597829913	NC_000017.11:31326029:T:TT
NM_001042492.3(NF1):c.4578-12dup	NF1		Neurofibromatosis, type 1	Benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803362	17	29588714 - 29588715	17	31261696 - 31261697	803362	791715	rs1597748630	NC_000017.11:31261696:TTT:TTTT
NM_001042492.3(NF1):c.4381dup (p.Met1461fs)	NF1	M1440fs, M1461fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803358	17	29586097 - 29586098	17	31259079 - 31259080	803358	791711	rs1597745689	NC_000017.11:31259079:A:AA
NM_001042492.3(NF1):c.4344_4345insCCT (p.Ile1449_Ala1450insPro)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803357	17	29586060 - 29586061	17	31259042 - 31259043	803357	791710	rs1597745583	NC_000017.11:31259042:T:TCCT
NM_001042492.3(NF1):c.3198-4dup	NF1		Neurofibromatosis, type 1|not provided|not specified	Benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000803349	17	29559061 - 29559062	17	31232043 - 31232044	803349	791702	rs371047262	NC_000017.11:31232043:TTTTTTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTTTTTTT
NM_001042492.3(NF1):c.2244dup (p.Ser749fs)	NF1	S749fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803346	17	29553694 - 29553695	17	31226676 - 31226677	803346	791699	rs1597712758	NC_000017.11:31226676:G:GG
NM_001042492.3(NF1):c.730+32dup	NF1		Neurofibromatosis, type 1|not specified|not provided	Benign(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000803339	17	29508819 - 29508820	17	31181801 - 31181802	803339	791692	rs71142032	NC_000017.11:31181801:TTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTT
NM_001042492.3(NF1):c.7851_7852delinsCT (p.Ala2617_Leu2618=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000798781	17	29684090 - 29684091	17	31357072 - 31357073	798781	785531	rs1597866565	NC_000017.11:31357071:GC:CT
NM_001042492.3(NF1):c.3198-4_3198-3insTGTTT	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000766493	17	29559084 - 29559085	17	31232066 - 31232067	766493	776281	rs1597718644	NC_000017.11:31232066:TTT:TTTTGTTT
NM_001042492.3(NF1):c.3198-6_3198-3dup	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000758288	17	29559084 - 29559085	17	31232066 - 31232067	758288	776632	rs1597718647	NC_000017.11:31232066:TTTC:TTTCTTTC
NM_001042492.3(NF1):c.2033_2034delinsTA (p.Pro678Leu)	NF1	P678L	Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV000707503	17	29553484 - 29553485	17	31226466 - 31226467	707503	694067	rs1597712334	NC_000017.11:31226465:CG:TA
NM_001042492.3(NF1):c.3198-4_3198-3dup	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000704588	17	29559086 - 29559087	17	31232068 - 31232069	704588	695735	rs1555614809	NC_000017.11:31232068:TC:TCTC
NM_001042492.3(NF1):c.2524_2531delinsAGCTTCCA (p.Gly842_Leu844delinsSerPheHis)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000694606	17	29556157 - 29556164	17	31229139 - 31229146	694606	682678	rs1597715286	NC_000017.11:31229138:GGCTTCCT:AGCTTCCA
NM_001042492.3(NF1):c.6847dup (p.Asp2283fs)	NF1	D2283fs, D2262fs	Neurofibromatosis, type 1	Pathogenic	criteria provided, single submitter	VCV000694512	17	29665748 - 29665749	17	31338730 - 31338731	694512	682499		NC_000017.11:31338730:G:GG
NM_001042492.3(NF1):c.3452dup (p.Asn1151fs)	NF1	N1151fs	Neurofibromatosis, type 1	Pathogenic	criteria provided, single submitter	VCV000694509	17	29559852 - 29559853	17	31232834 - 31232835	694509	682496		NC_000017.11:31232834:AAA:AAAA
NC_000017.10:g.(?_29540877)_(29563299_?)dup	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 23, 2018)	criteria provided, single submitter	VCV000666227	17	29540877 - 29563299	17	31213859 - 31236281	666227	653352		
NM_001042492.3(NF1):c.7152_7153insTT (p.Asn2385fs)	NF1	N2364fs, N2385fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000665552	17	29670115 - 29670116	17	31343097 - 31343098	665552	645731	rs1555535434	NC_000017.11:31343097:T:TTT
NM_001042492.3(NF1):c.7970+2dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000663112	17	29684388 - 29684389	17	31357370 - 31357371	663112	652776	rs1597867039	NC_000017.11:31357370:T:TT
NM_001042492.3(NF1):c.243_254delinsTGAGAGAGA (p.Ser82_Ile85delinsGluArgAsp)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 9, 2018)	criteria provided, single submitter	VCV000663004	17	29486066 - 29486077	17	31159048 - 31159059	663004	645445	rs1597629809	NC_000017.11:31159047:CTCTCAGTTGAT:TGAGAGAGA
NM_001042492.3(NF1):c.6835_6836dup (p.Leu2279fs)	NF1	L2258fs, L2279fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 29, 2018)	criteria provided, single submitter	VCV000662994	17	29665736 - 29665737	17	31338718 - 31338719	662994	645720	rs1597845926	NC_000017.11:31338718:TT:TTTT
NM_001042492.3(NF1):c.5469_5470insTT (p.Ile1824fs)	NF1	I1803fs, I1824fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000662174	17	29654716 - 29654717	17	31327698 - 31327699	662174	645670	rs267606605	NC_000017.11:31327698:T:TTT
NM_001042492.3(NF1):c.1414_1440dup (p.Val472_Lys480dup)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000662146	17	29541476 - 29541477	17	31214458 - 31214459	662146	645505	rs1597698326	NC_000017.11:31214458:ATTTAAAGAAAAAGTAACAAGCCTTAAATTTAAAGAAAAA:ATTTAAAGAAAAAGTAACAAGCCTTAAATTTAAAGAAAAAGTAACAAGCCTTAAATTTAAAGAAAAA
NM_001042492.3(NF1):c.4872dup (p.Tyr1625fs)	NF1	Y1604fs, Y1625fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000662034	17	29652873 - 29652874	17	31325855 - 31325856	662034	645649	rs1597829557	NC_000017.11:31325855:A:AA
NM_001042492.3(NF1):c.8270_8294dup (p.Leu2766fs)	NF1	L2745fs, L2766fs	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 17, 2018)	criteria provided, single submitter	VCV000661616	17	29687613 - 29687614	17	31360595 - 31360596	661616	645785	rs1597870232	NC_000017.11:31360595:CTCCCACATCTCCTTACCCTCCTGC:CTCCCACATCTCCTTACCCTCCTGCCTCCCACATCTCCTTACCCTCCTGC
NM_001042492.3(NF1):c.7917_7918insA (p.Tyr2640fs)	NF1	Y2640fs, Y2619fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000660273	17	29684334 - 29684335	17	31357316 - 31357317	660273	645767	rs1597866897	NC_000017.11:31357316::A
NM_001042492.3(NF1):c.1804dup (p.Glu602fs)	NF1	E602fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000659891	17	29550541 - 29550542	17	31223523 - 31223524	659891	645516	rs1597708762	NC_000017.11:31223523:GGG:GGGG
NM_001042492.3(NF1):c.8084_8089delinsA (p.Pro2695fs)	NF1	P2674fs, P2695fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000659275	17	29685611 - 29685616	17	31358593 - 31358598	659275	645780	rs1597868244	NC_000017.11:31358592:CACCAC:A
NM_001042492.3(NF1):c.2045_2049dup (p.Gln684fs)	NF1	Q684fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000658682	17	29553494 - 29553495	17	31226476 - 31226477	658682	645528	rs1597712398	NC_000017.11:31226476:CAAGCC:CAAGCCAAGCC
NM_001042492.3(NF1):c.8301_8322dup (p.Asn2775delinsGluProAlaTer)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000658513	17	29687644 - 29687645	17	31360626 - 31360627	658513	645786	rs1597870268	NC_000017.11:31360626:GAGCCAGCTTAGTATCACTGCC:GAGCCAGCTTAGTATCACTGCCGAGCCAGCTTAGTATCACTGCC
NM_001042492.3(NF1):c.4495delinsTG (p.Ile1499fs)	NF1	I1478fs, I1499fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000658301	17	29587451	17	31260433	658301	645636	rs1597747012	NC_000017.11:31260432:A:TG
NM_001042492.3(NF1):c.7325dup (p.Leu2442fs)	NF1	L2421fs, L2442fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 3, 2018)	criteria provided, single submitter	VCV000658066	17	29677201 - 29677202	17	31350183 - 31350184	658066	645743	rs1597859558	NC_000017.11:31350183:TTT:TTTT
NC_000017.10:g.(?_29575992)_(29576147_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000657394	17	29575992 - 29576147	17	31248974 - 31249129	657394	653091		
NM_001042492.3(NF1):c.3456dup (p.Leu1153fs)	NF1	L1153fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000656975	17	29559858 - 29559859	17	31232840 - 31232841	656975	645591	rs1430634618	NC_000017.11:31232840:A:AA
NM_001042492.3(NF1):c.3402_3405dup (p.Arg1136fs)	NF1	R1136fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000655579	17	29559803 - 29559804	17	31232785 - 31232786	655579	645588	rs1597719535	NC_000017.11:31232785:TGTCT:TGTCTGTCT
NM_001042492.3(NF1):c.1260+2dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000655355	17	29528504 - 29528505	17	31201486 - 31201487	655355	653397	rs1597682922	NC_000017.11:31201486:T:TT
NM_001042492.3(NF1):c.2695_2738dup (p.Arg914_Thr915insCysProTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000654522	17	29556327 - 29556328	17	31229309 - 31229310	654522	645550	rs1597715646	NC_000017.11:31229309:TTGTCCTTAATGGTGTGTAACCATGAGAAAGTGGGACTTCAAAT:TTGTCCTTAATGGTGTGTAACCATGAGAAAGTGGGACTTCAAATTTGTCCTTAATGGTGTGTAACCATGAGAAAGTGGGACTTCAAAT
NM_001042492.3(NF1):c.3186dup (p.Cys1063fs)	NF1	C1063fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000653648	17	29557928 - 29557929	17	31230910 - 31230911	653648	645578	rs1597717672	NC_000017.11:31230910:AAAA:AAAAA
NM_001042492.3(NF1):c.3461dup (p.Asn1154fs)	NF1	N1154fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000653419	17	29559862 - 29559863	17	31232844 - 31232845	653419	645592	rs1597719643	NC_000017.11:31232844:AA:AAA
NM_001042492.3(NF1):c.4738_4745delinsAAAAAGG (p.Glu1580fs)	NF1	E1580fs, E1559fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000653392	17	29592260 - 29592267	17	31265242 - 31265249	653392	645643	rs1597753176	NC_000017.11:31265241:GAAAAAGA:AAAAAGG
NM_001042492.3(NF1):c.2158dup (p.Arg720fs)	NF1	R720fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000652458	17	29553607 - 29553608	17	31226589 - 31226590	652458	645532	rs1597712619	NC_000017.11:31226589:CC:CCC
NM_001042492.3(NF1):c.4849_4853delinsATATCAG (p.Gln1617fs)	NF1	Q1596fs, Q1617fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000651932	17	29652851 - 29652855	17	31325833 - 31325837	651932	645648	rs1597829519	NC_000017.11:31325832:CAAAT:ATATCAG
NM_001042492.3(NF1):c.3370dup (p.Ser1124fs)	NF1	S1124fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000650810	17	29559770 - 29559771	17	31232752 - 31232753	650810	645586	rs1597719471	NC_000017.11:31232752:AAA:AAAA
NM_001042492.3(NF1):c.4832_4834delinsAC (p.Arg1611fs)	NF1	R1611fs, R1590fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000649126	17	29592354 - 29592356	17	31265336 - 31265338	649126	645646	rs1597753353	NC_000017.11:31265335:GGA:AC
NC_000017.10:g.(?_29701025)_(29701178_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 3, 2018)	criteria provided, single submitter	VCV000649082	17	29701025 - 29701178	17	31374007 - 31374160	649082	652633		
NM_001042492.3(NF1):c.1527+2dup	NF1		Neurofibromatosis, type 1|Inborn genetic diseases|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2021)	criteria provided, conflicting interpretations	VCV000648469	17	29541604 - 29541605	17	31214586 - 31214587	648469	652719	rs1597698533	NC_000017.11:31214586:T:TT
NM_001042492.3(NF1):c.221_222dup (p.Ala75fs)	NF1	A75fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000647297	17	29486043 - 29486044	17	31159025 - 31159026	647297	645442	rs1597629724	NC_000017.11:31159025:CT:CTCT
NM_000267.3(NF1):c.3047_3048insSVAelement	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000646558	17	29557334 - 29557335	17	31230316 - 31230317	646558	645568		
NM_001042492.3(NF1):c.7757_7758dup (p.Ser2587fs)	NF1	S2566fs, S2587fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000645292	17	29683995 - 29683996	17	31356977 - 31356978	645292	645759	rs1597866350	NC_000017.11:31356977:CA:CACA
NM_001042492.3(NF1):c.3447_3448dup (p.Ser1150fs)	NF1	S1150fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000644537	17	29559848 - 29559849	17	31232830 - 31232831	644537	645590	rs1597719619	NC_000017.11:31232830:TGT:TGTGT
NC_000017.10:g.(?_29701011)_(29701193_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000643152	17	29701011 - 29701193	17	31373993 - 31374175	643152	653104		
NM_001042492.3(NF1):c.6990_6991insATGAGG (p.Tyr2331_Ser2332insMetArg)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000640473	17	29667590 - 29667591	17	31340572 - 31340573	640473	645725	rs1597848085	NC_000017.11:31340572:G:GATGAGG
NM_001042492.3(NF1):c.5533dup (p.Ile1845fs)	NF1	I1845fs, I1824fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000640360	17	29654780 - 29654781	17	31327762 - 31327763	640360	645675	rs1597832360	NC_000017.11:31327762:A:AA
NM_001042492.3(NF1):c.338dup (p.Leu113fs)	NF1	L113fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000640096	17	29490251 - 29490252	17	31163233 - 31163234	640096	645450	rs1597635740	NC_000017.11:31163233:TT:TTT
NM_001042492.3(NF1):c.3378_3381dup (p.Gly1128fs)	NF1	G1128fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 18, 2018)	no assertion criteria provided	VCV000635499	17	29559778 - 29559779	17	31232760 - 31232761	635499	623345	rs1597719490	NC_000017.11:31232760:CAAACA:CAAACAAACA
NM_001042492.3(NF1):c.1528-9dup	NF1		not specified	Uncertain significance(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000633338	17	29546007 - 29546008	17	31218989 - 31218990	633338	621853	rs776722942	NC_000017.11:31218989:TTTTTTT:TTTTTTTT
NM_001042492.3(NF1):c.8139dup (p.Phe2714fs)	NF1	F2693fs, F2714fs	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000632277	17	29686010 - 29686011	17	31358992 - 31358993	632277	620581	rs1567628013	NC_000017.11:31358992:GG:GGG
NM_001042492.3(NF1):c.2545_2546dup (p.Val850fs)	NF1	V850fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584928	17	29556174 - 29556175	17	31229156 - 31229157	584928	575977	rs1567848878	NC_000017.11:31229156:GGGGG:GGGGGGG
NC_000017.10:g.(?_29701021)_(29701183_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000583849	17	29701021 - 29701183	17	31374003 - 31374165	583849	570778		
NC_000017.10:g.(?_29422318)_(29422397_?)dup	NF1|LOC111811965		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000583778	17	29422318 - 29422397	17	31095300 - 31095379	583778	570749		
NC_000017.10:g.(?_29652828)_(29657526_?)dup	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000583635	17	29652828 - 29657526	17	31325810 - 31330508	583635	570668		
NM_001042492.3(NF1):c.6316_6359dup (p.Ser2121_Thr2122insLeuLeuLeuSerTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000582963	17	29663819 - 29663820	17	31336801 - 31336802	582963	571027	rs1567617045	NC_000017.11:31336801:CGTTGTTACTTTCTTAGTAGCCACAGGTCCGCTCTCCCTTAGAGC:CGTTGTTACTTTCTTAGTAGCCACAGGTCCGCTCTCCCTTAGAGCGTTGTTACTTTCTTAGTAGCCACAGGTCCGCTCTCCCTTAGAGC
NM_001042492.3(NF1):c.3065_3073dup (p.Met1022_Ala1024dup)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000582013	17	29557349 - 29557350	17	31230331 - 31230332	582013	574398	rs1567849843	NC_000017.11:31230331:AATGATGGCAA:AATGATGGCAATGATGGCAA
NM_001042492.3(NF1):c.5645dup (p.Cys1882fs)	NF1	C1861fs, C1882fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000581320	17	29657348 - 29657349	17	31330330 - 31330331	581320	571144	rs1567613604	NC_000017.11:31330330:G:GG
NM_001042492.3(NF1):c.4743dup (p.Glu1582fs)	NF1	E1582fs, E1561fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000580651	17	29592260 - 29592261	17	31265242 - 31265243	580651	570998	rs1567864972	NC_000017.11:31265242:AAAAA:AAAAAA
NM_001042492.3(NF1):c.4516_4517delinsTT (p.Ala1506Phe)	NF1	A1506F, A1485F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000580544	17	29587472 - 29587473	17	31260454 - 31260455	580544	574409	rs1567862930	NC_000017.11:31260453:GC:TT
NM_001042492.3(NF1):c.5376_5379dup (p.Val1794fs)	NF1	V1794fs, V1773fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000580268	17	29654623 - 29654624	17	31327605 - 31327606	580268	571013	rs1567612435	NC_000017.11:31327605:CCTA:CCTACCTA
NM_001042492.3(NF1):c.6722dup (p.Asn2241fs)	NF1	N2241fs, N2220fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000579219	17	29665058 - 29665059	17	31338040 - 31338041	579219	574423	rs1567617849	NC_000017.11:31338040:AA:AAA
NM_001042492.3(NF1):c.2449dup (p.Met817fs)	NF1	M817fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000578345	17	29556080 - 29556081	17	31229062 - 31229063	578345	568849	rs1567848755	NC_000017.11:31229062:AA:AAA
NM_001042492.3(NF1):c.4703dup (p.Phe1569fs)	NF1	F1569fs, F1548fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000576754	17	29588851 - 29588852	17	31261833 - 31261834	576754	574410	rs1555619052	NC_000017.11:31261833:AAA:AAAA
NM_001042492.3(NF1):c.2148_2159delinsTGAAGTGTCT (p.Glu716fs)	NF1	E716fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000575987	17	29553599 - 29553610	17	31226581 - 31226592	575987	568833	rs1567847538	NC_000017.11:31226580:AGCAGATATCCG:TGAAGTGTCT
NM_001042492.3(NF1):c.7662_7664delinsAG (p.Lys2555fs)	NF1	K2555fs, K2534fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000575440	17	29683524 - 29683526	17	31356506 - 31356508	575440	571228	rs1567626632	NC_000017.11:31356505:TAA:AG
NM_001042492.3(NF1):c.4617_4630dup (p.Ala1544fs)	NF1	A1544fs, A1523fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000574435	17	29588767 - 29588768	17	31261749 - 31261750	574435	571119	rs1567863580	NC_000017.11:31261749:GGCAACACTTCTTG:GGCAACACTTCTTGGGCAACACTTCTTG
NM_001042492.3(NF1):c.3657dup (p.Glu1220fs)	NF1	E1220fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000573205	17	29560179 - 29560180	17	31233161 - 31233162	573205	571084	rs1567851445	NC_000017.11:31233161:A:AA
NM_001042492.3(NF1):c.5427dup (p.Leu1810fs)	NF1	L1810fs, L1789fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 18, 2018)	criteria provided, single submitter	VCV000570687	17	29654674 - 29654675	17	31327656 - 31327657	570687	571138	rs1567612483	NC_000017.11:31327656:G:GG
NM_001042492.3(NF1):c.1344dup (p.Lys449Ter)	NF1	K449*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000570222	17	29533340 - 29533341	17	31206322 - 31206323	570222	570876	rs1567838311	NC_000017.11:31206322:T:TT
NM_001042492.3(NF1):c.2338dup (p.Thr780fs)	NF1	T780fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000569066	17	29554552 - 29554553	17	31227534 - 31227535	569066	574386	rs1567848129	NC_000017.11:31227534:A:AA
NM_001042492.3(NF1):c.6861_6864dup (p.Val2289fs)	NF1	V2268fs, V2289fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, single submitter	VCV000568552	17	29665762 - 29665763	17	31338744 - 31338745	568552	571191	rs1567618250	NC_000017.11:31338744:TCAA:TCAATCAA
NM_001042492.3(NF1):c.5039_5041delinsT (p.Tyr1680fs)	NF1	Y1680fs, Y1659fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000567655	17	29653041 - 29653043	17	31326023 - 31326025	567655	568927	rs1567611457	NC_000017.11:31326022:ATA:T
NM_001042492.3(NF1):c.7701dup (p.Lys2568fs)	NF1	K2547fs, K2568fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547695	17	29683557 - 29683558	17	31356539 - 31356540	547695	538232	rs1060500295	NC_000017.11:31356539:CCCCCC:CCCCCCC
NM_001042492.3(NF1):c.7169_7178delinsCAGC (p.Leu2390_His2393delinsSerAla)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547693	17	29670133 - 29670142	17	31343115 - 31343124	547693	538230	rs1555535448	NC_000017.11:31343114:TGGTTGGACA:CAGC
NM_001042492.3(NF1):c.6979_6980insTA (p.Glu2327fs)	NF1	E2306fs, E2327fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547689	17	29667580 - 29667581	17	31340562 - 31340563	547689	538226	rs1555535171	NC_000017.11:31340562::TA
NM_001042492.3(NF1):c.6855dup (p.Asn2286fs)	NF1	N2286fs, N2265fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547684	17	29665756 - 29665757	17	31338738 - 31338739	547684	538221	rs1555535041	NC_000017.11:31338738:C:CC
NM_001042492.3(NF1):c.6833dup (p.Cys2278fs)	NF1	C2278fs, C2257fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547683	17	29665734 - 29665735	17	31338716 - 31338717	547683	538220	rs1555535027	NC_000017.11:31338716:G:GG
NM_001042492.3(NF1):c.6780_6791delinsATGAGAC (p.His2261_Ile2264delinsTer)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547682	17	29665118 - 29665129	17	31338100 - 31338111	547682	538219	rs1555534952	NC_000017.11:31338099:TCATGGGCAGAT:ATGAGAC
NM_001042492.3(NF1):c.6304dup (p.Tyr2102fs)	NF1	Y2102fs, Y2081fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547675	17	29663808 - 29663809	17	31336790 - 31336791	547675	538212	rs1555534712	NC_000017.11:31336790:T:TT
NM_001042492.3(NF1):c.6227_6228dup (p.Asp2077fs)	NF1	D2056fs, D2077fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547674	17	29663731 - 29663732	17	31336713 - 31336714	547674	538211	rs1555534680	NC_000017.11:31336713:AT:ATAT
NM_001042492.3(NF1):c.5676dup (p.Leu1893fs)	NF1	L1893fs, L1872fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547666	17	29657379 - 29657380	17	31330361 - 31330362	547666	538203	rs1475358670	NC_000017.11:31330361:A:AA
NM_001042492.3(NF1):c.5663dup (p.Glu1889fs)	NF1	E1889fs, E1868fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547664	17	29657366 - 29657367	17	31330348 - 31330349	547664	538201	rs1555533856	NC_000017.11:31330348:T:TT
NM_001042492.3(NF1):c.5560_5562delinsT (p.Leu1854fs)	NF1	L1833fs, L1854fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547662	17	29654808 - 29654810	17	31327790 - 31327792	547662	538199	rs1555533641	NC_000017.11:31327789:CTG:T
NM_001042492.3(NF1):c.5072_5073delinsCCC (p.Lys1691fs)	NF1	K1691fs, K1670fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547655	17	29653074 - 29653075	17	31326056 - 31326057	547655	538192	rs1555533363	NC_000017.11:31326055:AG:CCC
NM_001042492.3(NF1):c.5065dup (p.Tyr1689fs)	NF1	Y1689fs, Y1668fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547654	17	29653066 - 29653067	17	31326048 - 31326049	547654	538191	rs1555533359	NC_000017.11:31326048:T:TT
NM_001042492.3(NF1):c.4076_4077insA (p.Gln1360fs)	NF1	Q1360fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547640	17	29576103 - 29576104	17	31249085 - 31249086	547640	538177	rs1555617364	NC_000017.11:31249085::A
NM_001042492.3(NF1):c.3787_3788insT (p.Lys1263fs)	NF1	K1263fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547636	17	29562707 - 29562708	17	31235689 - 31235690	547636	538173	rs1555615467	NC_000017.11:31235689::T
NM_001042492.3(NF1):c.3288_3294dup (p.Lys1099fs)	NF1	K1099fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547624	17	29559180 - 29559181	17	31232162 - 31232163	547624	538161	rs1555614862	NC_000017.11:31232162:GGAAGCC:GGAAGCCGGAAGCC
NM_001042492.3(NF1):c.2876_2877insG (p.Phe960fs)	NF1	F960fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547619	17	29556878 - 29556879	17	31229860 - 31229861	547619	538156	rs1555614429	NC_000017.11:31229860::G
NM_001042492.3(NF1):c.2873_2877delinsTGG (p.Thr958fs)	NF1	T958fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547618	17	29556875 - 29556879	17	31229857 - 31229861	547618	538155	rs1555614426	NC_000017.11:31229856:CTCAA:TGG
NM_001042492.3(NF1):c.2846dup (p.Gln950fs)	NF1	Q950fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547616	17	29556477 - 29556478	17	31229459 - 31229460	547616	538153	rs1555614358	NC_000017.11:31229459:GG:GGG
NM_001042492.3(NF1):c.2842dup (p.Gln948fs)	NF1	Q948fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547615	17	29556472 - 29556473	17	31229454 - 31229455	547615	538152	rs1555614354	NC_000017.11:31229454:CCC:CCCC
NM_001042492.3(NF1):c.2739dup (p.Arg914fs)	NF1	R914fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547613	17	29556371 - 29556372	17	31229353 - 31229354	547613	538150	rs1555614319	NC_000017.11:31229353:A:AA
NM_001042492.3(NF1):c.2309_2315dup (p.Asn773fs)	NF1	N773fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547609	17	29554292 - 29554293	17	31227274 - 31227275	547609	538146	rs1555613926	NC_000017.11:31227274:CTGCAGG:CTGCAGGCTGCAGG
NM_001042492.3(NF1):c.2187dup (p.Asn730Ter)	NF1	N730*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547605	17	29553637 - 29553638	17	31226619 - 31226620	547605	538142	rs1555613821	NC_000017.11:31226619:T:TT
NM_001042492.3(NF1):c.2035dup (p.Ile679fs)	NF1	I679fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547604	17	29553485 - 29553486	17	31226467 - 31226468	547604	538141	rs1555613773	NC_000017.11:31226467:A:AA
NM_001042492.3(NF1):c.1413_1414delinsT (p.Lys471fs)	NF1	K471fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547590	17	29541489 - 29541490	17	31214471 - 31214472	547590	538127	rs1555612273	NC_000017.11:31214470:AG:T
NM_001042492.3(NF1):c.1073_1074insA (p.Phe358fs)	NF1	F358fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547581	17	29528065 - 29528066	17	31201047 - 31201048	547581	538118	rs1555610971	NC_000017.11:31201047::A
NM_001042492.3(NF1):c.1020dup (p.Val341fs)	NF1	V341fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000545745	17	29527570 - 29527571	17	31200552 - 31200553	545745	536487	rs1555610905	NC_000017.11:31200552:T:TT
NC_000017.10:g.(?_29587367)_(29592377_?)dup	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000527684	17	29587367 - 29592377	17	31260349 - 31265359	527684	530834		
NM_001042492.3(NF1):c.3431_3432dup (p.Thr1145fs)	NF1	T1145fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000527598	17	29559832 - 29559833	17	31232814 - 31232815	527598	530783	rs1555614966	NC_000017.11:31232814:TGT:TGTGT
NM_001042492.3(NF1):c.909_910delinsTT (p.Arg304Ter)	NF1	R304*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000527594	17	29527460 - 29527461	17	31200442 - 31200443	527594	530942	rs1555610854	NC_000017.11:31200441:AC:TT
NM_001042492.3(NF1):c.181dup (p.Ile61fs)	NF1	I61fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000527552	17	29483120 - 29483121	17	31156102 - 31156103	527552	530914	rs1555604935	NC_000017.11:31156102:A:AA
NM_001042492.3(NF1):c.920_921delinsA (p.Leu307fs)	NF1	L307fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000527551	17	29527471 - 29527472	17	31200453 - 31200454	527551	530873	rs1555610860	NC_000017.11:31200452:TT:A
NM_001042492.3(NF1):c.7989dup (p.Lys2664Ter)	NF1	K2643*, K2664*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV000527531	17	29685515 - 29685516	17	31358497 - 31358498	527531	531142	rs1555536882	NC_000017.11:31358497:T:TT
NM_001042492.3(NF1):c.4571_4572delinsAA (p.Ser1524Lys)	NF1	S1503K, S1524K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527528	17	29587527 - 29587528	17	31260509 - 31260510	527528	530852	rs1555618860	NC_000017.11:31260508:GC:AA
NM_001042492.3(NF1):c.4983_4985delinsCTTA (p.Lys1661fs)	NF1	K1661fs, K1640fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000527499	17	29652985 - 29652987	17	31325967 - 31325969	527499	530867	rs1555533326	NC_000017.11:31325966:GTG:CTTA
NM_001042492.3(NF1):c.1423dup (p.Leu475fs)	NF1	L475fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000527489	17	29541497 - 29541498	17	31214479 - 31214480	527489	530708	rs1555612274	NC_000017.11:31214479:CC:CCC
NM_001042492.3(NF1):c.529dup (p.Ile177fs)	NF1	I177fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000527453	17	29496957 - 29496958	17	31169939 - 31169940	527453	530842	rs1555607093	NC_000017.11:31169939:A:AA
NM_001042492.3(NF1):c.3094dup (p.Cys1032fs)	NF1	C1032fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000527429	17	29557377 - 29557378	17	31230359 - 31230360	527429	530953	rs1555614535	NC_000017.11:31230359:TTTT:TTTTT
NM_001042492.3(NF1):c.6726_6727insGGAAA (p.Ser2243fs)	NF1	S2222fs, S2243fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527428	17	29665063 - 29665064	17	31338045 - 31338046	527428	531363	rs1555534950	NC_000017.11:31338045:A:AGGAAA
NM_001042492.3(NF1):c.693_694delinsCT (p.Thr232Ser)	NF1	T232S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000527424	17	29508766 - 29508767	17	31181748 - 31181749	527424	530682	rs1555608748	NC_000017.11:31181747:TA:CT
NM_001042492.3(NF1):c.616_617insGG (p.Lys206fs)	NF1	K206fs	Neurofibromatosis type 6	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523349	17	29508469 - 29508470	17	31181451 - 31181452	523349	514073	rs1555608663	NC_000017.11:31181451::GG
NM_001042492.3(NF1):c.1393-2dup	NF1		Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Feb 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000504049	17	29541466 - 29541467	17	31214448 - 31214449	504049	495666	rs1394021280	NC_000017.11:31214448:A:AA
NM_001042492.3(NF1):c.4669dup (p.Thr1557fs)	NF1	T1536fs, T1557fs	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503769	17	29588819 - 29588820	17	31261801 - 31261802	503769	495672	rs1555619033	NC_000017.11:31261801:A:AA
NM_001042492.3(NF1):c.7152dup (p.Asn2385Ter)	NF1	N2385*, N2364*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000492888	17	29670115 - 29670116	17	31343097 - 31343098	492888	485780	rs1555535434	NC_000017.11:31343097:T:TT
NM_001042492.3(NF1):c.5317dup (p.Leu1773fs)	NF1	L1752fs, L1773fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 23, 2014)	no assertion criteria provided	VCV000492885	17	29654563 - 29654564	17	31327545 - 31327546	492885	485777	rs1555533561	NC_000017.11:31327545:CC:CCC
NM_001042492.3(NF1):c.3111dup (p.Arg1038Ter)	NF1	R1038*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 22, 2016)	no assertion criteria provided	VCV000492880	17	29557395 - 29557396	17	31230377 - 31230378	492880	485772	rs1131691127	NC_000017.11:31230377:TTT:TTTT
NM_001042492.3(NF1):c.125_126dup (p.Leu43fs)	NF1	L43fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 13, 2015)	no assertion criteria provided	VCV000492872	17	29483063 - 29483064	17	31156045 - 31156046	492872	485764	rs1555604897	NC_000017.11:31156045:TGT:TGTGT
NM_001042492.3(NF1):c.7956dup (p.Val2653fs)	NF1	V2632fs, V2653fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000457861	17	29684370 - 29684371	17	31357352 - 31357353	457861	467913	rs1555536765	NC_000017.11:31357352:AAA:AAAA
NM_001042492.3(NF1):c.7745dup (p.Arg2583fs)	NF1	R2583fs, R2562fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000457853	17	29683983 - 29683984	17	31356965 - 31356966	457853	467569	rs1555536683	NC_000017.11:31356965:A:AA
NM_001042492.3(NF1):c.7458-7_7459delinsT	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000457847	17	29679268 - 29679276	17	31352250 - 31352258	457847	466713	rs1555536334	NC_000017.11:31352249:CTTTCAGGA:T
NM_001042492.3(NF1):c.7189+8dup	NF1		Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Jul 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457825	17	29670155 - 29670156	17	31343137 - 31343138	457825	467885	rs753952604	NC_000017.11:31343137:AAAAAA:AAAAAAA
NM_001042492.3(NF1):c.6900dup (p.Leu2301fs)	NF1	L2280fs, L2301fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 19, 2017)	criteria provided, single submitter	VCV000457811	17	29665799 - 29665800	17	31338781 - 31338782	457811	467879	rs1555535050	NC_000017.11:31338781:AAA:AAAA
NM_001042492.3(NF1):c.6365_6366insGG (p.His2123fs)	NF1	H2123fs, H2102fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000457791	17	29663870 - 29663871	17	31336852 - 31336853	457791	466667	rs1555534751	NC_000017.11:31336852::GG
NM_001042492.3(NF1):c.6090dup (p.Met2031fs)	NF1	M2010fs, M2031fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000457779	17	29663433 - 29663434	17	31336415 - 31336416	457779	467678	rs1555534611	NC_000017.11:31336415:G:GG
NM_001042492.3(NF1):c.5013_5017dup (p.Asn1673fs)	NF1	N1652fs, N1673fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000457734	17	29653013 - 29653014	17	31325995 - 31325996	457734	467484	rs1555533336	NC_000017.11:31325995:ACGACA:ACGACACGACA
NM_001042492.3(NF1):c.4074_4075delinsAA (p.Pro1359Thr)	NF1	P1359T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457678	17	29576101 - 29576102	17	31249083 - 31249084	457678	467757	rs1555617362	NC_000017.11:31249082:CC:AA
NM_001042492.3(NF1):c.3484dup (p.Met1162fs)	NF1	M1162fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000457651	17	29559886 - 29559887	17	31232868 - 31232869	457651	467504	rs1555614977	NC_000017.11:31232868:A:AA
NM_001042492.3(NF1):c.3214dup (p.Ser1072fs)	NF1	S1072fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000457634	17	29559105 - 29559106	17	31232087 - 31232088	457634	467405	rs1555614825	NC_000017.11:31232087:AA:AAA
NM_001042492.3(NF1):c.3198-5_3198-4insC	NF1		Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457633	17	29559086 - 29559087	17	31232068 - 31232069	457633	467702	rs1555614804	NC_000017.11:31232068::C
NM_001042492.3(NF1):c.3198-4_3198-3insTTTC	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 14, 2019)	criteria provided, single submitter	VCV000457632	17	29559087 - 29559088	17	31232069 - 31232070	457632	467704	rs864622717	NC_000017.11:31232069::TTTC
NM_001042492.3(NF1):c.3198-4_3198-3insTTC	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 26, 2020)	criteria provided, single submitter	VCV000457631	17	29559087 - 29559088	17	31232069 - 31232070	457631	467399	rs864622717	NC_000017.11:31232069::TTC
NM_001042492.3(NF1):c.2969_2970dup (p.Met991fs)	NF1	M991fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000457609	17	29556969 - 29556970	17	31229951 - 31229952	457609	467653	rs1555614458	NC_000017.11:31229951:ACA:ACACA
NM_001042492.3(NF1):c.2866dup (p.Thr956fs)	NF1	T956fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000457604	17	29556867 - 29556868	17	31229849 - 31229850	457604	466513	rs1555614418	NC_000017.11:31229849:A:AA
NM_001042492.3(NF1):c.2710dup (p.Cys904fs)	NF1	C904fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000457590	17	29556342 - 29556343	17	31229324 - 31229325	457590	467635	rs1555614310	NC_000017.11:31229324:T:TT
NM_001042492.3(NF1):c.2064dup (p.Val689fs)	NF1	V689fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000457561	17	29553513 - 29553514	17	31226495 - 31226496	457561	466477	rs1555613786	NC_000017.11:31226495:AA:AAA
NM_001042492.3(NF1):c.1882dup (p.Tyr628fs)	NF1	Y628fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457553	17	29552143 - 29552144	17	31225125 - 31225126	457553	467285	rs1555613558	NC_000017.11:31225125:TTTTTT:TTTTTTT
NC_000017.10:g.(?_29546017)_(29585526_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000457507	17	29546017 - 29585526			457507	467331		
NC_000017.10:g.(?_29422322)_(29592363_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000457501	17	29422322 - 29592363			457501	467319		
NC_000017.10:g.(?_29422322)_(29497021_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 9, 2019)	criteria provided, single submitter	VCV000457500	17	29422322 - 29497021			457500	467073		
NM_001042492.3(NF1):c.6088dup (p.Val2030fs)	NF1	V2030fs, V2009fs	not provided	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000452757	17	29663430 - 29663431	17	31336412 - 31336413	452757	445752	rs1555534609	NC_000017.11:31336412:GG:GGG
NM_001042492.3(NF1):c.3737dup (p.Phe1247fs)	NF1	F1247fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000450458	17	29562656 - 29562657	17	31235638 - 31235639	450458	445741	rs1555615445	NC_000017.11:31235638:T:TT
NM_001042492.3(NF1):c.724dup (p.Met242fs)	NF1	M242fs	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000449421	17	29508796 - 29508797	17	31181778 - 31181779	449421	445731	rs1555608763	NC_000017.11:31181778:A:AA
NM_001042492.3(NF1):c.7409dup (p.Asn2470fs)	NF1	N2449fs, N2470fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000431692	17	29677284 - 29677285	17	31350266 - 31350267	431692	425197	rs1135402906	NC_000017.11:31350266:AAAA:AAAAA
NM_001042492.3(NF1):c.7260dup (p.Asn2421Ter)	NF1	N2400*, N2421*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431687	17	29676206 - 29676207	17	31349188 - 31349189	431687	425192	rs1135402901	NC_000017.11:31349188:TT:TTT
NM_001042492.3(NF1):c.6462dup (p.Glu2155fs)	NF1	E2134fs, E2155fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431673	17	29664419 - 29664420	17	31337401 - 31337402	431673	425178	rs1135402888	NC_000017.11:31337401:A:AA
NM_001042492.3(NF1):c.6452_6456delinsA (p.Leu2151fs)	NF1	L2130fs, L2151fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431672	17	29664410 - 29664414	17	31337392 - 31337396	431672	425177	rs1135402887	NC_000017.11:31337391:TCAGT:A
NM_001042492.3(NF1):c.5843dup (p.Tyr1948Ter)	NF1	Y1927*, Y1948*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431665	17	29661885 - 29661886	17	31334867 - 31334868	431665	425170	rs1135402881	NC_000017.11:31334867:A:AA
NM_001042492.3(NF1):c.5672dup (p.Leu1892fs)	NF1	L1871fs, L1892fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431662	17	29657375 - 29657376	17	31330357 - 31330358	431662	425167	rs1135402878	NC_000017.11:31330357:A:AA
NM_001042492.3(NF1):c.5571_5572delinsT (p.Ala1858fs)	NF1	A1837fs, A1858fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431659	17	29654819 - 29654820	17	31327801 - 31327802	431659	425163	rs1135402875	NC_000017.11:31327800:CG:T
NM_001042492.3(NF1):c.4998dup (p.Pro1667fs)	NF1	P1646fs, P1667fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431650	17	29652995 - 29652996	17	31325977 - 31325978	431650	425155	rs1135402867	NC_000017.11:31325977:TTTTT:TTTTTT
NM_001042492.3(NF1):c.3732dup (p.Thr1245fs)	NF1	T1245fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431629	17	29562650 - 29562651	17	31235632 - 31235633	431629	425134	rs1135402849	NC_000017.11:31235632:TT:TTT
NM_001042492.3(NF1):c.3591dup (p.Glu1198fs)	NF1	E1198fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431624	17	29560113 - 29560114	17	31233095 - 31233096	431624	425129	rs1135402844	NC_000017.11:31233095:A:AA
NM_001042492.3(NF1):c.3429_3432dup (p.Thr1145fs)	NF1	T1145fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431621	17	29559831 - 29559832	17	31232813 - 31232814	431621	425126	rs1135402842	NC_000017.11:31232813:CTGT:CTGTCTGT
NM_001042492.3(NF1):c.1918dup (p.Thr640fs)	NF1	T640fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431602	17	29552184 - 29552185	17	31225166 - 31225167	431602	425107	rs1135402825	NC_000017.11:31225166:A:AA
NM_001042492.3(NF1):c.1883_1885delinsCC (p.Tyr628fs)	NF1	Y628fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431600	17	29552150 - 29552152	17	31225132 - 31225134	431600	425105	rs1135402823	NC_000017.11:31225131:ACG:CC
NM_001042492.3(NF1):c.1525dup (p.Cys509fs)	NF1	C509fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431588	17	29541598 - 29541599	17	31214580 - 31214581	431588	425093	rs1135402813	NC_000017.11:31214580:TTT:TTTT
NM_001042492.3(NF1):c.1374dup (p.Ala459fs)	NF1	A459fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431581	17	29533370 - 29533371	17	31206352 - 31206353	431581	425086	rs1135402806	NC_000017.11:31206352:A:AA
NM_001042492.3(NF1):c.610dup (p.Leu204fs)	NF1	L204fs	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000431567	17	29508460 - 29508461	17	31181442 - 31181443	431567	425072	rs1135402793	NC_000017.11:31181442:CCC:CCCC
NM_001042492.3(NF1):c.7838dup (p.Lys2614fs)	NF1	K2593fs, K2614fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000429012	17	29684075 - 29684076	17	31357057 - 31357058	429012	420835	rs1131691129	NC_000017.11:31357057:CC:CCC
NM_001042492.3(NF1):c.5469dup (p.Ile1824fs)	NF1	I1803fs, I1824fs	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428957	17	29654716 - 29654717	17	31327698 - 31327699	428957	420811	rs267606605	NC_000017.11:31327698:T:TT
NM_001042492.3(NF1):c.2034delinsCA (p.Ile679fs)	NF1	I679fs	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jul 9, 2021)	criteria provided, single submitter	VCV000423262	17	29553485	17	31226467	423262	409865	rs1064796331	NC_000017.11:31226466:G:CA
NM_001042492.3(NF1):c.6006_6006+1delinsAA	NF1		not provided	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000422898	17	29662049 - 29662050	17	31335031 - 31335032	422898	409878	rs1064796077	NC_000017.11:31335030:GG:AA
NM_001042492.3(NF1):c.7870-13dup	NF1		Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 4, 2021)	criteria provided, conflicting interpretations	VCV000420689	17	29684268 - 29684269	17	31357250 - 31357251	420689	409886	rs369360556	NC_000017.11:31357250:TTTTTT:TTTTTTT
NM_001042492.3(NF1):c.7330dup (p.Thr2444fs)	NF1	T2423fs, T2444fs	not specified|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420081	17	29677208 - 29677209	17	31350190 - 31350191	420081	409883	rs1064794278	NC_000017.11:31350190:A:AA
NC_000017.10:g.(?_29421945)_(29509683_?)dup	NF1|LOC108281169|LOC108281170|LOC108281180|LOC111811965		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 1, 2016)	criteria provided, single submitter	VCV000417338	17	29421945 - 29509683	17	31094927 - 31182665	417338	401476		
NC_000017.10:g.(?_29701031)_(29704695_?)dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000417333	17	29701031 - 29704695	17	31374013 - 31377677	417333	401511		
NM_001042492.3(NF1):c.3198-4_3198-3insTC	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, single submitter	VCV000413011	17	29559087 - 29559088	17	31232069 - 31232070	413011	401704	rs864622717	NC_000017.11:31232069::TC
NM_001042492.3(NF1):c.1343dup (p.His448fs)	NF1	H448fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000404616	17	29533339 - 29533340	17	31206321 - 31206322	404616	401641	rs1555611584	NC_000017.11:31206321:A:AA
NM_001042492.3(NF1):c.5908_5909insTA (p.Arg1970fs)	NF1	R1949fs, R1970fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000404569	17	29661950 - 29661951	17	31334932 - 31334933	404569	401828	rs1060500354	NC_000017.11:31334932:A:ATA
NM_001042492.3(NF1):c.4574dup (p.Asn1525fs)	NF1	N1525fs, N1504fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000404564	17	29587528 - 29587529	17	31260510 - 31260511	404564	401757	rs1555618862	NC_000017.11:31260510:AA:AAA
NM_001042492.3(NF1):c.2619dup (p.Lys874Ter)	NF1	K874*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000404563	17	29556251 - 29556252	17	31229233 - 31229234	404563	401668	rs1555614284	NC_000017.11:31229233:T:TT
NM_001042492.3(NF1):c.5083_5084dup (p.Leu1696fs)	NF1	L1675fs, L1696fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000404561	17	29653083 - 29653084	17	31326065 - 31326066	404561	401805	rs1555533366	NC_000017.11:31326065:GCG:GCGCG
NM_001042492.3(NF1):c.5731_5734dup (p.Ser1912delinsAsnTer)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 10, 2016)	criteria provided, single submitter	VCV000404545	17	29657434 - 29657435	17	31330416 - 31330417	404545	401825	rs1555533871	NC_000017.11:31330416:ATTA:ATTAATTA
NM_001042492.3(NF1):c.4747_4748dup (p.Phe1584fs)	NF1	F1563fs, F1584fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000404532	17	29592267 - 29592268	17	31265249 - 31265250	404532	401784	rs1555619397	NC_000017.11:31265249:AGA:AGAGA
NM_001042492.3(NF1):c.3198-5_3198-3dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000404508	17	29559085 - 29559086	17	31232067 - 31232068	404508	402219	rs1227046003	NC_000017.11:31232067:TTC:TTCTTC
NM_001042492.3(NF1):c.1469_1470insTTAT (p.Lys490fs)	NF1	K490fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	VCV000404503	17	29541545 - 29541546	17	31214527 - 31214528	404503	401642	rs1060500307	NC_000017.11:31214527::TTAT
NM_001042492.3(NF1):c.2729dup (p.Leu911fs)	NF1	L911fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 15, 2016)	criteria provided, single submitter	VCV000404466	17	29556359 - 29556360	17	31229341 - 31229342	404466	401697	rs1555614313	NC_000017.11:31229341:GGG:GGGG
NM_001042492.3(NF1):c.3198-4_3198-3insTGT	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2020)	criteria provided, single submitter	VCV000404445	17	29559086 - 29559087	17	31232068 - 31232069	404445	402228	rs745559136	NC_000017.11:31232068:T:TTGT
NM_001042492.3(NF1):c.4293_4294dup (p.Pro1432fs)	NF1	P1411fs, P1432fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 19, 2016)	criteria provided, single submitter	VCV000404424	17	29585479 - 29585480	17	31258461 - 31258462	404424	402276	rs1555618552	NC_000017.11:31258461:CAC:CACAC
NM_001042492.3(NF1):c.3250_3251dup (p.Gln1086fs)	NF1	Q1086fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000404423	17	29559141 - 29559142	17	31232123 - 31232124	404423	401710	rs1555614845	NC_000017.11:31232123:CCC:CCCCC
NM_001042492.3(NF1):c.*2638_*2646delinsTTATG	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000322601	17	29703811 - 29703819	17	31376793 - 31376801	322601	327988	rs886052813	NC_000017.11:31376792:GATAATCTA:TTATG
NM_001042492.3(NF1):c.730+16dup	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2016)	criteria provided, conflicting interpretations	VCV000322568	17	29508818 - 29508819	17	31181800 - 31181801	322568	337803	rs373999174	NC_000017.11:31181800:A:AA
NM_001042492.3(NF1):c.2665dup (p.Thr889fs)	NF1	T889fs	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280056	17	29556297 - 29556298	17	31229279 - 31229280	280056	265014	rs886041348	NC_000017.11:31229279:A:AA
NM_000267.3(NF1):c.129_130ins568 (p.?)	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000254097	17	29483069 - 29483070	17	31156051 - 31156052	254097	248528		
NM_000267.3(NF1):c.-383_60+?dup443	NF1|LOC111811965		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000254085	17	29421945 - 29422387	17	31094927 - 31095369	254085	248514		
NM_001042492.3(NF1):c.7931dup (p.Glu2645fs)	NF1	E2645fs, E2624fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000237600	17	29684347 - 29684348	17	31357329 - 31357330	237600	242711	rs878853918	NC_000017.11:31357329:C:CC
NM_000267.3(NF1):c.7395-?_*3522+?dup	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 16, 2016)	criteria provided, single submitter	VCV000237596					237596	242578		
NM_001042492.3(NF1):c.4483dup (p.Ser1495fs)	NF1	S1495fs, S1474fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 13, 2016)	criteria provided, single submitter	VCV000237568	17	29587438 - 29587439	17	31260420 - 31260421	237568	242686	rs878853896	NC_000017.11:31260420:A:AA
NM_001042492.3(NF1):c.3197+9dup	NF1		not provided|not specified|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237546	17	29557945 - 29557946	17	31230927 - 31230928	237546	242666	rs755212937	NC_000017.11:31230927:AAAAAAA:AAAAAAAA
NM_001042492.3(NF1):c.2604dup (p.Pro869fs)	NF1	P869fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 13, 2018)	criteria provided, single submitter	VCV000237538	17	29556236 - 29556237	17	31229218 - 31229219	237538	242658	rs878853877	NC_000017.11:31229218:T:TT
NM_001042492.3(NF1):c.955dup (p.Ser319fs)	NF1	S319fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000234213	17	29527503 - 29527504	17	31200485 - 31200486	234213	235533	rs876660931	NC_000017.11:31200485:AAA:AAAA
NM_001042492.3(NF1):c.5730dup (p.Ile1911fs)	NF1	I1911fs, I1890fs	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000233126	17	29657433 - 29657434	17	31330415 - 31330416	233126	235750	rs876660212	NC_000017.11:31330415:T:TT
NM_001042492.3(NF1):c.4819dup (p.Tyr1607fs)	NF1	Y1607fs, Y1586fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230301	17	29592335 - 29592336	17	31265317 - 31265318	230301	235704	rs876658492	NC_000017.11:31265317:TTTTTT:TTTTTTT
NM_001042492.3(NF1):c.6854dup (p.Tyr2285Ter)	NF1	Y2264*, Y2285*	Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Sep 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000228382	17	29665755 - 29665756	17	31338737 - 31338738	228382	230771	rs876657715	NC_000017.11:31338737:A:AA
NM_001042492.3(NF1):c.6952dup (p.Val2318fs)	NF1	V2318fs, V2297fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000223148	17	29667550 - 29667551	17	31340532 - 31340533	223148	224875	rs1057519369	NC_000017.11:31340532:GGG:GGGG
NM_001042492.3(NF1):c.7063-7_7063-6delinsC	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000221040	17	29670020 - 29670021	17	31343002 - 31343003	221040	222629	rs864622725	NC_000017.11:31343001:TT:C
NM_001042492.3(NF1):c.3198-3dup	NF1		Neurofibromatosis, type 1	Benign(Last reviewed: Dec 7, 2020)	criteria provided, single submitter	VCV000220995	17	29559087 - 29559088	17	31232069 - 31232070	220995	222591	rs1555614816	NC_000017.11:31232069:C:CC
NM_001042492.3(NF1):c.7970+149_8160+723dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217114	17	29684534 - 29684535	17	31357516 - 31357517	217114	213737		
NM_000267.3(NF1):c.4773-1597_7395-685dup	NF1|LOC108281182		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217113	17	29651241 - 29678590	17	31324223 - 31351572	217113	213721		
NM_000267.3(NF1):c.[4110+1791_7394+859dup;4110+1798del]	NF1|EVI2A|OMG|EVI2B		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217112	17|17	29577935	17|17	31250917	217112	213715|213714	rs863224944	NC_000017.11:31250916:AAAAA:AAAA
NM_000267.3(NF1):c.3496+57_4772+2639dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217111	17	29559956 - 29594996	17	31232938 - 31267978	217111	213710		
NM_001042492.3(NF1):c.2851-151_2990+121dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217110	17	29556697 - 29556698	17	31229679 - 31229680	217110	213709	rs1555614386	
NM_001042492.3(NF1):c.2252-70_2326-39dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217109	17	29554163 - 29554164	17	31227145 - 31227146	217109	213707	rs1555613896	
NM_000267.3(NF1):c.1527+443_3709-761dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217108	17	29542046 - 29561868	17	31215028 - 31234850	217108	213700		
NM_000267.3(NF1):c.1393-1905_2251+85dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217107	17	29539564 - 29553787	17	31212546 - 31226769	217107	213699		
NM_001042492.3(NF1):c.61-6522_204+1022dup	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217105	17	29476478 - 29476479	17	31149460 - 31149461	217105	213677		
NM_000267.3:c.7566_8314+3321_delinsCGCCACGGC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217103					217103	213758		
NM_000267.3(NF1):c.5943+265_7000-999delins15	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217098	17	29662314 - 29669028	17	31335296 - 31342010	217098	213731		
NM_000267.3(NF1):c.5749+6_6858+633delins130	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217096	17	29657522 - 29666456	17	31330504 - 31339438	217096	213724		
NM_001042492.3(NF1):c.5813-1748_6247delinsCTA	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217095	17	29660108 - 29663752	17	31333090 - 31336734	217095	213727		
NM_000267.3(NF1):c.4773-2116_7127-1817delinsAGTTACC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217086	17	29650722 - 29674321	17	31323704 - 31347303	217086	213720		
NM_000267.3(NF1):c.4662-1076_4772+1300delins260	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217081	17	29591171 - 29593657	17	31264153 - 31266639	217081	213717		
NM_000267.3(NF1):c.4368-391_4515-122delins105	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217080	17	29586996 - 29588607	17	31259978 - 31261589	217080	213716		
NM_001042492.3(NF1):c.3975-1922_4174-2448delinsTTTACTTAGGT	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217078	17	29574080 - 29582914	17	31247062 - 31255896	217078	213713		
NM_000267.3:c.3975-1046_4110+902deins333	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217077					217077	213752		
NM_000267.3(NF1):c.3709-266_7259-397delinsCAG	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217076					217076	213751		
NM_001042492.3(NF1):c.2410-110_2850+65delinsAAAA	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217073	17	29555933 - 29556548	17	31228915 - 31229530	217073	213708	rs1555614169	
NM_000267.3(NF1):c.1846-613_4773-1009delinsTTAGGTTTAT	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217071					217071	213749		
NM_001042492.3(NF1):c.1988_2410-218delinsTGTC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217069	17	29552255 - 29555825	17	31225237 - 31228807	217069	213706		
NM_001042492.3(NF1):c.1846-496_2410-645delinsTAGC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217068	17	29551617 - 29555398	17	31224599 - 31228380	217068	213705		
NM_001042492.3(NF1):c.1393-2488_1642-648delinsAATAG	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217063	17	29538981 - 29548220	17	31211963 - 31221202	217063	213698		
NM_000267.3(NF1):c.888+8334_1721+34delinsTC	NF1		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217057	17	29518017 - 29548981	17	31190999 - 31221963	217057	213692		
NM_000267.3(NF1):c.655-60_888+5621delins135	NF1|LOC108281181		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217051	17	29508668 - 29515304	17	31181650 - 31188286	217051	213690		
NM_000267.3(NF1):c.586+2095_1261-2276delinsGTGG	NF1|LOC108281181		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217047	17	29499110 - 29530982	17	31172092 - 31203964	217047	213687		
NM_000267.3(NF1):c.480-2832_888+5938delinsTTGAA	NF1|LOC108281181		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217044	17	29494077 - 29515621	17	31167059 - 31188603	217044	213686		
NM_000267.3(NF1):c.288+230_480-1812delins323	NF1|LOC108281180		Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000217039	17	29486341 - 29495097	17	31159323 - 31168079	217039	213680		
NM_001042492.3(NF1):c.7797dup (p.Glu2600Ter)	NF1	E2579*, E2600*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000216867	17	29684035 - 29684036	17	31357017 - 31357018	216867	213299	rs863224837	NC_000017.11:31357017:T:TT
NM_001042492.3(NF1):c.1738dup (p.Tyr580fs)	NF1	Y580fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 2, 2014)	criteria provided, single submitter	VCV000188397	17	29550472 - 29550473	17	31223454 - 31223455	188397	186245	rs786204255	NC_000017.11:31223454:TTTTTT:TTTTTTT
NM_001042492.3(NF1):c.3821dup (p.Phe1275fs)	NF1	F1275fs	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187286	17	29562740 - 29562741	17	31235722 - 31235723	187286	184641	rs786203614	NC_000017.11:31235722:T:TT
NM_001042492.3(NF1):c.1392+5_1392+6delinsTT	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 18, 2021)	criteria provided, conflicting interpretations	VCV000142958	17	29533394 - 29533395	17	31206376 - 31206377	142958	152672	rs587782851	NC_000017.11:31206375:GA:TT
NM_001042492.3(NF1):c.2033dup (p.Ile679fs)	NF1	I679fs	Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudoarthrosis|Hereditary cancer-predisposing syndrome|none provided|not provided	Pathogenic(Last reviewed: Oct 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000141513	17	29553477 - 29553478	17	31226459 - 31226460	141513	151227	rs587781807	NC_000017.11:31226459:CCCCCCC:CCCCCCCC
NM_001042492.3(NF1):c.945_946delinsAA (p.Leu316Met)	NF1	L316M	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000000366	17	29527496 - 29527497	17	31200478 - 31200479	366	15405	rs267606609	NC_000017.11:31200477:GC:AA
NM_001042492.3(NF1):c.4095_4096insTG (p.His1366fs)	NF1	H1366fs	Neurofibromatosis-Noonan syndrome	Pathogenic(Last reviewed: May 15, 2003)	no assertion criteria provided	VCV000000365	17	29576122 - 29576123	17	31249104 - 31249105	365	15404	rs267606608	NC_000017.11:31249104::TG
NM_001042492.3(NF1):c.8105dup (p.Tyr2702Ter)	NF1	Y2702*, Y2681*	Neurofibromatosis, familial spinal	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000000349	17	29685631 - 29685632	17	31358613 - 31358614	349	15388	rs267606601	NC_000017.11:31358613:A:AA
NM_001042492.3(NF1):c.5528_5529insT (p.Lys1844fs)	NF1	K1823fs, K1844fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000000338	17	29654776 - 29654777	17	31327758 - 31327759	338	15377	rs267606597	NC_000017.11:31327758::T
NM_001042492.3(NF1):c.5511dup (p.Ser1838fs)	NF1	S1838fs, S1817fs	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000000337	17	29654758 - 29654759	17	31327740 - 31327741	337	15376	rs267606596	NC_000017.11:31327740:C:CC
NF1, ALU INS	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 31, 1991)	no assertion criteria provided	VCV000000332					332	15371		
NM_000268.4(NF2):c.457dup (p.Tyr153fs)	NF2	Y111fs, Y112fs, Y153fs, Y70fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV001074791	22	30050654 - 30050655	22	29654665 - 29654666	1074791	1065010		NC_000022.11:29654665:T:TT
NM_000268.4(NF2):c.648_649dup (p.Tyr217fs)	NF2	Y134fs, Y175fs, Y176fs, Y217fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV001070353	22	30054224 - 30054225	22	29658235 - 29658236	1070353	1065012		NC_000022.11:29658235:TGT:TGTGT
NM_000268.4(NF2):c.1493_1494delinsCT (p.Phe498Ser)	NF2	F415S, F456S, F457S, F498S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV001061051	22	30074231 - 30074232	22	29678242 - 29678243	1061051	1052071		NC_000022.11:29678241:TC:CT
NM_000268.4(NF2):c.1395_1396delinsAT (p.Arg466Ter)	NF2	R383*, R424*, R425*, R466*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV000998281	22	30070879 - 30070880	22	29674890 - 29674891	998281	986118		NC_000022.11:29674889:GC:AT
NM_000268.4(NF2):c.1613dup (p.Leu539fs)	NF2	L456fs, L497fs, L498fs, L539fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, single submitter	VCV000995902	22	30077465 - 30077466	22	29681476 - 29681477	995902	983611		NC_000022.11:29681476:A:AA
NM_000268.4(NF2):c.470_479dup (p.Gly161fs)	NF2	G119fs, G120fs, G161fs, G78fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, single submitter	VCV000995901	22	30050666 - 30050667	22	29654677 - 29654678	995901	983610		NC_000022.11:29654677:GTTCACAAGCG:GTTCACAAGCGTTCACAAGCG
NM_000268.4(NF2):c.319_325delinsTAGGATA (p.Glu107_Leu109delinsTer)	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000970254	22	30035157 - 30035163	22	29639168 - 29639174	970254	959061		NC_000022.11:29639167:GAGGAGC:TAGGATA
NM_000268.4(NF2):c.251dup (p.His84fs)	NF2	H42fs, H84fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000861060	22	30035088 - 30035089	22	29639099 - 29639100	861060	849189		NC_000022.11:29639099:A:AA
NM_000268.4(NF2):c.431dup (p.Tyr144Ter)	NF2	Y144*, Y102*, Y103*, Y61*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000855264	22	30038257 - 30038258	22	29642268 - 29642269	855264	849194		NC_000022.11:29642268:A:AA
NC_000022.11:g.(?_29603989)_(29604122_?)dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000833475	22	29999978 - 30000111			833475	821437		
NC_000022.11:g.(?_29603999)_(29604122_?)dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000832848	22	29999988 - 30000111			832848	821443		
NC_000022.11:g.(?_29636741)_(29694812_?)dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000832491	22	30032730 - 30090801			832491	821446		
NC_000022.11:g.(?_29603999)_(29694802_?)dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 7, 2019)	criteria provided, single submitter	VCV000831848	22	29999988 - 30090791			831848	821445		
NC_000022.11:g.(?_29603989)_(29694812_?)dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000831754	22	29999978 - 30090801			831754	821440		
NM_000268.4(NF2):c.69dup (p.Val24fs)	NF2	V24fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000644553	22	30000054 - 30000055	22	29604065 - 29604066	644553	649331	rs1601515970	NC_000022.11:29604065:CC:CCC
NC_000022.10:g.(?_30090731)_(30090801_?)dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000583752	22	30090731 - 30090801	22	29694742 - 29694812	583752	573219		
NM_000268.4(NF2):c.810_810+2dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000568174	22	30057327 - 30057328	22	29661338 - 29661339	568174	574065	rs1569297926	NC_000022.11:29661338:GGT:GGTGGT
NM_000268.4(NF2):c.1507dup (p.Asp503fs)	NF2	D503fs, D420fs, D462fs, D461fs	Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547708	22	30074244 - 30074245	22	29678255 - 29678256	547708	538258	rs1556002536	NC_000022.11:29678255:G:GG
NM_000268.4(NF2):c.58_61delinsGT (p.Lys20fs)	NF2	K20fs	Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547703	22	30000045 - 30000048	22	29604056 - 29604059	547703	538253	rs1555978369	NC_000022.11:29604055:AAGA:GT
NC_000022.10:g.(?_29999982)_(30000107_?)dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000527727	22	29999982 - 30000107	22	29603993 - 29604118	527727	534034		
NM_000268.4(NF2):c.656_657insA (p.Asn220fs)	NF2	N137fs, N179fs, N178fs, N220fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000457925	22	30054234 - 30054235	22	29658245 - 29658246	457925	470115	rs1555994819	NC_000022.11:29658245::A
NM_000268.4(NF2):c.1738-4_1741delinsG	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000457909	22	30090737 - 30090744	22	29694748 - 29694755	457909	471495	rs1556008383	NC_000022.11:29694747:ACAGCTCA:G
NC_000022.10:g.(?_30077422)_(30077596_?)dup	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000457885	22	30077422 - 30077596	22	29681433 - 29681607	457885	469860		
Single allele	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000457884			22	29674830 - 29694808	457884	471786		
NM_000268.4(NF2):c.*2039dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341133	22	30092828 - 30092829	22	29696839 - 29696840	341133	351326	rs886057371	NC_000022.11:29696839:GG:GGG
NM_000268.4(NF2):c.*2031_*2032dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341132	22	30092813 - 30092814	22	29696824 - 29696825	341132	347354	rs11442202	NC_000022.11:29696824:TTTTTTTTTT:TTTTTTTTTTTT
NM_000268.4(NF2):c.*2032dup	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341131	22	30092813 - 30092814	22	29696824 - 29696825	341131	351324	rs11442202	NC_000022.11:29696824:TTTTTTTTTT:TTTTTTTTTTT
NM_000268.4(NF2):c.*2021dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341129	22	30092811 - 30092812	22	29696822 - 29696823	341129	351322	rs886057369	NC_000022.11:29696822:T:TT
NM_000268.4(NF2):c.*2007dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341125	22	30092784 - 30092785	22	29696795 - 29696796	341125	352362	rs886057365	NC_000022.11:29696795:TTTTTTTTTTTTTT:TTTTTTTTTTTTTTT
NM_000268.4(NF2):c.*1287dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341104	22	30092055 - 30092056	22	29696066 - 29696067	341104	347334	rs886057354	NC_000022.11:29696066:TTTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTTTT
NM_000268.4(NF2):c.*1260dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341102	22	30092048 - 30092049	22	29696059 - 29696060	341102	352352	rs886057352	NC_000022.11:29696059:CCC:CCCC
NM_000268.4(NF2):c.*768_*769dup	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341095	22	30091557 - 30091558	22	29695568 - 29695569	341095	352351	rs886057348	NC_000022.11:29695568:GAG:GAGAG
NM_152594.3(SPRED1):c.794dup (p.Asp265fs)	SPRED1	D265fs	Legius syndrome	Pathogenic(Last reviewed: Feb 18, 2020)	criteria provided, single submitter	VCV001068945	15	38643323 - 38643324	15	38351122 - 38351123	1068945	1063232		NC_000015.10:38351122:A:AA
NM_152594.3(SPRED1):c.462_464dup (p.His155dup)	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001041948	15	38631974 - 38631975	15	38339773 - 38339774	1041948	1031971		NC_000015.10:38339773:ATCA:ATCATCA
NM_152594.3(SPRED1):c.177dup (p.Ile60fs)	SPRED1	I60fs	Legius syndrome	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000955012	15	38591712 - 38591713	15	38299511 - 38299512	955012	948852		NC_000015.10:38299511:TTTTTT:TTTTTTT
NM_152594.3(SPRED1):c.355dup (p.Ala119fs)	SPRED1	A119fs	Legius syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000943158	15	38614588 - 38614589	15	38322387 - 38322388	943158	936900		NC_000015.10:38322387:G:GG
NM_152594.3(SPRED1):c.395dup (p.Asn132fs)	SPRED1	N132fs	Legius syndrome	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000848498	15	38616976 - 38616977	15	38324775 - 38324776	848498	842242		NC_000015.10:38324775:AAAAAA:AAAAAAA
NM_152594.3(SPRED1):c.306_307dup (p.Phe103fs)	SPRED1	F103fs	Legius syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000650362	15	38614539 - 38614540	15	38322338 - 38322339	650362	643118	rs1595746834	NC_000015.10:38322338:GT:GTGT
NM_152594.3(SPRED1):c.900dup (p.Lys301Ter)	SPRED1	K301*	Legius syndrome	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000640306	15	38643429 - 38643430	15	38351228 - 38351229	640306	643123	rs1595763656	NC_000015.10:38351228:T:TT
NM_152594.3(SPRED1):c.326_329dup (p.Arg110delinsSerTer)	SPRED1		not provided|Legius syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000636663	15	38614558 - 38614559	15	38322357 - 38322358	636663	624494	rs1595746858	NC_000015.10:38322357:GCTAG:GCTAGCTAG
NM_152594.3(SPRED1):c.234dup (p.Asp79fs)	SPRED1	D79fs	Legius syndrome	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000573472	15	38614462 - 38614463	15	38322261 - 38322262	573472	573217	rs1566867209	NC_000015.10:38322261:AAAAAA:AAAAAAA
NM_152594.3(SPRED1):c.384dup (p.Glu129fs)	SPRED1	E129fs	Legius syndrome	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000568389	15	38616967 - 38616968	15	38324766 - 38324767	568389	566991	rs1566868022	NC_000015.10:38324766:CCCC:CCCCC
NM_152594.3(SPRED1):c.1044_1046delinsC (p.Arg349fs)	SPRED1	R349fs	Legius syndrome	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000565472	15	38643574 - 38643576	15	38351373 - 38351375	565472	573221	rs1566876929	NC_000015.10:38351372:TAG:C
NM_152594.3(SPRED1):c.1225_1226delinsTT (p.Ala409Phe)	SPRED1	A409F	not specified|Legius syndrome|not provided|Noonan syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2020)	criteria provided, conflicting interpretations	VCV000561784	15	38643755 - 38643756	15	38351554 - 38351555	561784	552852	rs1566877075	NC_000015.10:38351553:GC:TT
NM_152594.3(SPRED1):c.880_881dup (p.Ser295fs)	SPRED1	S295fs	Legius syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547792	15	38643409 - 38643410	15	38351208 - 38351209	547792	538028	rs1555392750	NC_000015.10:38351208:TA:TATA
NM_152594.3(SPRED1):c.290_291delinsGA (p.Lys97Arg)	SPRED1	K97R	Legius syndrome	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000536697	15	38614524 - 38614525	15	38322323 - 38322324	536697	529110	rs1555391042	NC_000015.10:38322322:AG:GA
NM_152594.3(SPRED1):c.304dup (p.Thr102fs)	SPRED1	T102fs	Legius syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000536688	15	38614537 - 38614538	15	38322336 - 38322337	536688	529256	rs1555391053	NC_000015.10:38322336:A:AA
NM_152594.3(SPRED1):c.1196dup (p.Phe400fs)	SPRED1	F400fs	Legius syndrome	Likely pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000468790	15	38643724 - 38643725	15	38351523 - 38351524	468790	464174	rs1555392791	NC_000015.10:38351523:AA:AAA
NM_152594.3(SPRED1):c.*5090dup	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000315788	15	38648948 - 38648949	15	38356747 - 38356748	315788	340368	rs141174183	NC_000015.10:38356747:TTTTTTT:TTTTTTTT
